key: cord-0044590-qldczrni
authors: Kim, Stephen S.; Albanese, Craig T.
title: Necrotizing Enterocolitis
date: 2012-03-21
journal: Pediatric Surgery
DOI: 10.1016/b978-0-323-02842-4.50095-4
sha: cdb65fc9a1d7d0ae11a1f0cab807a8572c19f366
doc_id: 44590
cord_uid: qldczrni

nan

Chapter Necrotizing Enterocolitis

Stephen S. Kim and Craig T. Albanese

Necrotizing enterocolitis (NEC) is a leading cause of morbidity and mortality in neonatal intensive care units (NICUs) around the world. Advances in perinatal and neonatal care have contributed to a growing population of premature infants at risk for NEC. It is now the most common newborn surgical emergency, with a mortality rate that far exceeds that of any other gastrointestinal (GI) condition requiring surgical intervention. Despite extensive research, the precise cause and pathogenesis remain elusive.

In 1888, Paltauf 223 described five patients who died of overwhelming peritonitis, the cause being suggestive of NEC in three of them. Despite this report, many credit Generisch 88 with publishing the first report of NEC in 1891, but on careful review of his description of the findings, it almost certainly was a case of meconium peritonitis rather than NEC.

In 1939, Thelander 289 reported 16 cases of perforation of the stomach, 30 of the duodenum, and 39 of the small and large intestines. Many of the patients who had intestinal perforations probably had NEC. The first report of a successfully treated infant with a localized ileal perforation as a result of NEC is attributed to Agerty et al. 2 in 1943. In 1953, Schmid and Quaiser 264 first used the term necrotizing enterocolitis. In 1959, Rossier and colleagues 249 described 15 infants, 14 of whom died of "ulcerative-necrotic enterocolitis of the premature."

In 1964, Berdon et al. 22 reported the clinical and radiographic findings of 21 patients with NEC. A year later, Mizrahi et al. 195 reported 18 cases of NEC in premature infants. The incidence of NEC in the New York Babies' Hospital nursery between 1953 and 1963 was 0.9%, but the disease caused 2.3% of all nursery deaths. In 1975, Santulli et al. 257 hypothesized that development of the disease had three essential components: injury to the intestinal mucosa, the presence of bacteria, and the availability of a metabolic substrate.

During the 1960s, treatment of NEC was early surgery. By 1970 it was recognized that with early diagnosis, most patients could be managed without surgery. In 1978, Bell et al. 21 published a severity-based classification scheme that was helpful in selecting therapy and allowing comparison of outcomes. In 1979, the International Classification of Diseases established a code for death from NEC, thereby allowing more precise epidemiologic and outcome analyses.

The true incidence of NEC is unknown. It varies significantly within the United States and worldwide. NEC accounts for 1% to 7% of all NICU admissions in the United States, or 1 to 3 cases per 1000 live births. 100, 102, 131, 152 In infants born with very low birth weight (VLBW, <1500 g), the disease occurs in approximately 10% to 12%, but ranges between 2% and 22%, depending on the center of inquiry. 44, 51, 131, 174, 291 Worldwide, the incidence of NEC in VLBW infants varies from 1% to 2% in Japan, 7% in Austria, 10% in Greece, 14% in Argentina, and 28% in Hong Kong. 44, 76, 101, 131, 271 Several confounding factors may account for this variability, including the number and survival of low-birthweight infants, the source of patient referrals (in-or outborn), and the diagnostic criteria used. A relatively large multicenter survey of VLBW infants noted an incidence of 10.1% for definite NEC and 17.2% for suspected NEC, although there was considerable intercenter variability. 291 In another study, the incidence of definite NEC versus suspected NEC was 8.6% and 18.6%, respectively. 152 In a report by Pokorny et al. 234 of more than 18,000 in-born neonates, including 1735 low-birth-weight infants, the incidence of NEC was 3 per 1000 live births. This and many other series may be underestimating the frequency of NEC because the incidence is often defined as the total number of cases of NEC divided by the total number of patients admitted to the NICU. Thus, these figures may include many premature infants who die within the first 3 days of life of cardiorespiratory disease and do not live long enough for NEC to develop. One study that excluded early neonatal deaths and included only infants who had been fed reported an incidence of 15%. 146 Most recent reports demonstrate a strong association between NEC and prematurity, with preterm babies of low gestational age and birth weight being at particular risk. It is estimated that only 7% to 13% of all NEC cases occur in full-term infants. 27, 221, 311 The advent of early surfactant therapy and improved methods of mechanical ventilation has resulted in significant improvement in the survival of low-and extremely low-birth-weight infants. 51, 113 As a result, an increasing population of tiny infants is now at risk for the development of NEC. In the future, NEC may surpass respiratory distress syndrome as the principal cause of death in premature infants. 141 

Age and Maturity NEC is predominantly a disease of premature low-birthweight infants rather than those who are small for gestational age. Kliegman and Fanaroff 142 reported that the mean gestational age of 123 patients with NEC was 31 weeks (average birth weight, 1460 g). Only 7.3% of the patients were full-term and 10.5% were small for gestational age. Infants with extremely low birth weight (<1000 g) and those 28 weeks' gestational age or less are at greatest risk. 115, 254 In a large multicenter prospective study involving 4438 infants weighing between 501 and 1500 g, Lemons et al. 174 demonstrated an inverse relationship between the incidence of NEC and birth weight. The incidence of NEC was highest in infants weighing between 501 and 750 g (14%) and declined with increasing weight: 751 to 1000 g (9%), 1001 to 1250 g (5%), 1251 to 1500 g (3%).

Tesdale et al. 288 reported an inverse relationship between the age at onset of NEC and gestational age. Infants in whom NEC developed in the first week of life were more mature (average gestational age, 36.1 weeks) than those in whom NEC developed after 1 week of age (average gestational age, 33.4 weeks). Complications were more common and the mortality rate was higher in patients with early-onset disease. Ostlie et al. 221 demonstrated a similar inverse relationship between gestational age and the onset of NEC. Full-term (≥38 weeks) infants had a significantly earlier onset of NEC (4.9 days) than did preterm (<38 weeks) infants (13 days) . Similarly, Martinez-Tallo et al. 187 also demonstrated an earlier onset of NEC (3.3 days) in infants with a birth weight greater than 2000 g.

Wilson et al. 310 calculated the birth weight-specific, weekly attack rate in patients with NEC. The risk period for NEC decreased as birth weight increased. They found a consistent pattern of sharply declining risk with attainment of age equivalent to 35 to 36 weeks' gestation. It was suggested that functional maturation of the GI tract may play a principal role in determining the risk for NEC. The preterm GI tract has decreased gastric acid production and lower levels of protective mucus, 19, 213 increased mucosal permeability, 292 and an absence of normal coordinated peristaltic activity until around 34 to 35 weeks' gestation. 19, 213 Feedings NEC develops in approximately 90% of infants after being fed, whereas it develops in only 10% or less before feedings are initiated. 144, 147, 157, 185, 281 In 1978, Brown and Sweet 33 proposed that aggressive feeding protocols contributed to the pathogenesis of NEC. They found that before they changed to a slowly progressive feeding regimen in July 1974, 14 cases of NEC occurred in 1745 lowbirth-weight infants. From July 1974 to June 1978, when a cautious approach to feeding was practiced, only 1 case developed in 932 low-birth-weight infants and 2557 total patients admitted to the NICU. In a longitudinal cohort study reviewing the incidence of NEC for a 3-year period before and after implementing a "standardized feeding schedule" for infants weighing between 1250 and 2500 g and less than 35 weeks' gestation, Kamitsuka et al. 132 reported an 84% reduction in the risk for NEC. Other studies have also suggested an association between an increase in the incidence of NEC and advancement of formula feedings at rates greater than 20 kcal/kg/day. 9, 165, 291, 313 Despite these reports, however, randomized trials have failed to demonstrate any difference in the incidence of NEC related to fast versus slow, early versus delayed, or continuous versus intermittent bolus feedings. 136, 137, 238, 243 In a randomized trial involving 185 VLBW infants in which slow (15-mL/kg/day increments; 10-day schedule to full feeding) and fast (35-mL/kg/day increments; 5-day schedule to full feeding) feeding advancements were compared, Rayyis et al. 243 demonstrated no significant difference in the incidence of NEC (13% versus 9%), perforation (4% versus 2%), and mortality (2% versus 3%) in both groups. In a review of randomized trials comparing continuous versus intermittent bolus tube feeding for premature infants weighing less than 1500 g, Premji and Chessell 238 could find no significant differences in the incidence of NEC between the two groups.

In a recent randomized trial investigating the incidence of NEC in VLBW infants assigned to receive either minimal-volume feeding (20 mL/kg/day) for 10 days before advancing to full-volume feeding or a standard feeding advancement protocol (starting at 20 mL/kg and increasing by 20 mL/kg/day to full-volume feeding), Berseth et al. 24 reported a significantly lower incidence of NEC in the minimal-volume group than in the standard group (1.4% versus 10%). The difference in the risk for NEC was so great that the study was closed early. The prolonged use of "trophic feeding" volumes is thought to trigger maturation of GI function. This study reinforces previous studies that gut stimulation protocols are beneficial to VLBW infants 71 and that initiation of a minimal-volume feeding protocol for 7 to 10 days followed by modest advancement of feeding may greatly reduce the incidence of NEC. 258 

The osmolarity and composition of enteral feedings have also been associated with an increase in the incidence of NEC. Formulas with high osmolarity have been shown to increase the incidence of NEC in infants and cause intestinal mucosal injury in animal models. De Lemos et al. 65 demonstrated intestinal lesions resembling NEC in newborn goats that were fed a hyperosmolar formula. Book et al. 29 prospectively studied 16 preterm infants fed either an elemental (650 mOsm/kg of body weight) or a milk (350 mOsm/kg) formula and found that NEC developed in 85% of the infants fed the elemental diet and 25% of the infants fed the milk formula. Grantmyre and associates 96 described one patient in whom fatal NEC developed after a Renografin-76 (osmolality, 1900 mOsm/kg) enema was administered for the treatment of meconium ileus.

Many oral medications, such as vitamin preparations, use hyperosmolar vehicles that could potentially lead to mucosal injury in the bowel. Willis et al. 309 reported a significantly higher incidence of NEC in infants fed undiluted calcium lactate (osmolality, 1700 mOsm/kg) than in infants fed no calcium or those fed calcium lactate diluted with water or formula. White and Harkavy 306 reported that many oral medications commonly used in the intensive care nursery have very high osmolality, even when mixed with formula, and that it is usually the vehicle rather than the medication itself that is responsible for the high osmolality. Finer et al. 82 reported a 13.4% incidence of NEC in preterm infants receiving an oral hyperosmolar vitamin E preparation as compared with a 5.7% incidence in infants who were given a parenteral preparation of vitamin E. The proposed mechanism of injury from the introduction of hyperosmolar solution into the GI tract, though not proved clinically, has been a reduction in intestinal mucosal blood flow secondary to rapid fluid shifts from the intravascular space into the bowel lumen. 108, 252, 255 How relevant this mechanism of intestinal injury in the development of NEC is in the clinical setting is unknown.

Xanthine derivatives (e.g., theophylline, aminophylline), which are known to slow intestinal motility and produce oxygen free radicals during their metabolism to uric acid, have been reported to be associated with NEC. In 1980, Williams 307 and Robinson et al. 248 described three patients in whom NEC developed after receiving oral and intravenous xanthines for apnea of prematurity. In animal experiments, Cronin et al. 59 demonstrated alterations in GI blood flow and oxygen delivery after aminophylline administration in newborn lambs that may result in depletion of the GI oxygen reserve and mucosal injury. Despite these earlier reports, subsequent results in large patient studies have failed to confirm this association. 63, 112 Administration of large doses of vitamin E to premature infants has been linked to an increase in NEC. 124 Vitamin E is given to reduce the incidence of adverse sequelae of retinopathy in premature infants and has been shown to interfere with intracellular killing of bacteria by leukocytes. The increased incidence of NEC, however, has been noted only after oral administration of hyperosmolar preparations and not after intramuscular administration. 82 Indomethacin blocks prostaglandin synthetase and causes vasoconstriction. This effect has been exploited to close the patent ductus arteriosus (PDA) in premature infants with congestive heart failure. GI perforation and NEC have been noted in low-birth-weight infants treated with high-dose indomethacin. 7, 98, 162 It has been postulated that indomethacin increases mesenteric vascular resistance and reduces mesenteric blood flow by 16% to 20%. 99 Norton et al. 215 demonstrated that the use of indomethacin as a tocolytic agent was associated with an increased incidence of NEC in babies delivered before 30 weeks' gestational age (mean age at delivery, 27.6 weeks); however, indomethacin did not increase the incidence of NEC in babies born after 32 weeks' gestation. In a retrospective study involving 252 premature infants with symptomatic PDA treated with intravenous indomethacin, Grosfeld et al. 97 found a 35% incidence of NEC. In contrast, two randomized controlled trials involving more than 500 low-birth-weight premature infants receiving early low-dose indomethacin versus placebo for closure of PDA demonstrated no difference in the subsequent incidence of NEC. 89, 183 Indomethacin by itself may not be enough to cause NEC; however, in the setting of hypoxia, heart failure, or sepsis, its adverse GI effects contribute to the development of NEC in VLBW infants. 156 

Cocaine has very potent vasoconstrictive properties, and with the dramatic increase in its abuse since the 1980s, it has been implicated as a risk factor for NEC. 235, 265, 286 In addition to its vasoconstrictive effects, cocaine has also been shown to block the reuptake of catecholamines at nerve terminals, thereby resulting in increased circulating levels of catecholamines in pregnant women. 312 Prenatal cocaine exposure has been associated with many adverse perinatal events, including stillbirths, abruptio placentae, intrauterine growth retardation, preterm delivery, sudden infant death syndrome, and maternal hypertension. 16, 70, 125 The proposed mechanism involves increased uterine vascular resistance, decreased uterine blood flow, and chronic placental insufficiency with accompanying fetal hypoxemia, hypertension, and tachycardia. 37, 110, 202 Despite these concerns, there have been few studies investigating the vascular and inflammatory effects of cocaine on the neonatal GI tract. Studies in pregnant rats exposed to cocaine demonstrated severe inflammatory changes in the uterus, placenta, and GI tract of the embryos. 37 Newborn piglets receiving high doses of cocaine had a prolonged increase in mesenteric vascular resistance and a decrease in mesenteric blood flow by Doppler evaluation. 110 In a study using radiolabeling techniques in which pregnant and nonpregnant rats were compared, exposure to cocaine resulted in a significant dose-dependent decrease in perfusion of the uterus, placenta, and fetus in the pregnant group but no change in perfusion of the uterus in the nonpregnant animals. 138 In retrospective studies involving infants with confirmed NEC, several differences have been reported between infants with and without prenatal exposure to cocaine. Czyrko et al. 61 noted a significantly greater need for surgical intervention (72.7% versus 38%), higher incidence of massive intestinal gangrene (54% versus 12%), and higher mortality (54.5% versus 18%) in infants with prenatal cocaine exposure than in those without exposure. Case-controlled analysis matching for race, sex, and birth weight demonstrated a 2.5-fold increased risk for the development of NEC in the cocaine-exposed group versus the nonexposed group. Lopez et al. 178 reported a 12% incidence of NEC in infants exposed to cocaine as compared with 3% in nonexposed babies. In addition, NEC developed in a significantly greater number of infants within the first 7 days of life in the cocaine-exposed group. In a retrospective cohort study of infants with a birth weight between 750 and 1500 g, Hand et al. 106 compared 48 infants prenatally exposed to only cocaine with 101 infants who had no drug exposure. There was no significant difference in the incidence of NEC between the two groups.

Despite the well-known adverse effects of cocaine, it is difficult to establish a definite causal relationship with NEC. Mothers who abuse cocaine during pregnancy report an ill-defined duration and extent of use, may have used it at a remote time before delivery, and may not have had adequate prenatal care. In addition, maternal cocaine use may be associated with the use of other recreational drugs, alcohol, and tobacco, and thus these mothers are at higher risk for having a baby who is premature or small for gestational age, or both.

Cytokines and growth factors play a critical role in mediating the proliferation, maturation, chemotaxis, and activation of hematopoietic and immune-related cells. It is recognized that cytokines and growth factors have important effects on a number of cells from various tissues, including those in the GI tract (Table 92-1) . Intestinal cells are exposed to cytokines secreted by intestinal endothelial cells, by mucosal fibroblasts, and by enterocytes themselves. 172, 214, 224, 226, 316 Epidermal growth factor (EGF) is known to be an important trophic factor for the developing GI tract. EGF receptors have been demonstrated throughout the fetal and neonatal intestine. 50, 57, 126, 184 EGF is secreted into the gut lumen primarily by the salivary glands and Brunner glands of the duodenum and has been shown to be present in high concentration in human breast milk. 233, 244 Significantly reduced levels of salivary and serum EGF have been demonstrated in premature infants in whom NEC developed versus age-matched controls. 111, 267 Inactivation of the EGF receptor in knockout mice has been shown to result in a hemorrhagic enteritis that is histologically similar to NEC. 191 In studies using a neonatal rat model of NEC that involved exposure to asphyxia and cold stress, enterally administered supplements of EGF have been shown to significantly decrease the incidence and severity of NEC in rat pups, 72 thus suggesting that this protective effect may be mediated by down-regulation of the proinflammatory cytokine interleukin-18 (IL-18) and increased production of the anti-inflammatory cytokine IL-10. 103 Fagbemi et al. 80 investigated the association of NEC with EGF receptors in the intestinal mucosa of preterm infants undergoing resection for severe NEC and confirmed the presence of intact EGF receptors located on the basolateral membrane of enterocytes.

Erythropoietin (Epo) is a growth factor produced by the kidneys that regulates red blood cell production in response to anemia. Since development of the recombinant protein, rEpo has become widely used in the NICU. 127, 218 Epo has been found in human breast milk, and functional Epo receptors have been demonstrated in fetal and neonatal small intestine, thus suggesting a possible role in GI development. 128, 130, 149 In a retrospective study comparing 260 VLBW infants who received rEpo with 233 matched controls, Ledbetter and Juul 171 demonstrated a significantly lower incidence of NEC in the rEpo group (4.6%) than in the control group (10.8%). Studies in neonatal rats given rEpo enterally have demonstrated a dose-dependent increase in intestinal mucosal villus surface area and increased cellular proliferation, thus suggesting a role of rEpo as a trophic factor in the developing small intestine. 129 In a neonatal rat model of NEC involving exposure to hypoxia and reoxygenation, pretreatment with intraperitoneal injections of rEpo resulted in significantly decreased mucosal inflammation and necrosis, which was thought to be mediated by decreased production of nitric oxide (NO). 163 Cytokines are endogenous mediators of the inflammatory cascade. Proinflammatory and anti-inflammatory cytokine production is tightly regulated by complex feedback mechanisms to maintain homeostasis. 285, 297 Overproduction of either may have significant untoward effects. Overproduction of proinflammatory cytokines (IL-1, IL-2, IL-6, IL-8, IL-12, tumor necrosis factor-α [TNF-α], interferon-γ, platelet-activating factor [PAF]) may lead to shock, multiorgan failure, and death. 188, 232 Overproduction of anti-inflammatory cytokines (IL-4, IL-10, IL-11) may result in excessive suppression of immune function. 28, 83 A number of different inflammatory mediators have been implicated in the pathogenesis of NEC. 47, 107 In vitro studies comparing the response of mature human intestinal cell lines and fetal intestinal cell lines to inflammatory stimulation by TNF-α, IL-1β, or lipopolysaccharide (LPS) demonstrated an exaggerated secretion of IL-8 by the fetal cells. 56, 210 Pretreatment of cells with Epo inhibited TNF-α-induced IL-8 secretion to control levels. In a study evaluating serial serum levels of two proinflammatory cytokines (IL-1β, IL-8) and two anti-inflammatory cytokines (IL-1 receptor antagonist [IL-ra], IL-10) in infants with NEC, Edelson et al. 73 demonstrated significantly higher levels of IL-8 and IL-10 in infants with severe NEC from the onset of disease through 24 hours than in infants with less severe NEC. They noted that counter-regulatory mediators in premature infants are secreted in appropriate concentrations, are released later after the onset of disease, and may be useful as a marker of more severe disease. Nadler et al. 209 investigated the pattern of cytokine expression in infants undergoing resection for severe NEC and infants undergoing intestinal resection for other inflammatory conditions. Significant up-regulation of IL-8 mRNA was seen in the specimens from infants with NEC as compared with controls. In addition, they noted significant up-regulation of IL-11 mRNA in infants with NEC and found an inverse correlation between IL-11 expression and the likelihood of pan-necrosis, thus suggesting that IL-11 secretion may be an adaptive response to limit the extent of intestinal damage. Several of the interleukins (IL-4, IL-10, IL-11) have been shown to have a protective or trophic role in the GI tract. IL-4 has been demonstrated to possess cytoprotective effects in human intestinal epithelial cells by reducing bacterial translocation, increasing leukocyte superoxide production, and inducing decay-accelerating factor, which protects the host from the attack of autologous complement activation. 10,268 IL-10 is known to be a potent anti-inflammatory cytokine that inhibits the production of proinflammatory cytokines. 168 In a neonatal rat hypoxia-reoxygenation model of NEC, recombinant IL-10 administered subcutaneously was found to significantly attenuate the extent of intestinal injury when compared with control animals, thus suggesting a protective effect of its anti-inflammatory properties. 222 has been shown to be a pleiotropic cytokine that promotes epithelial regeneration and enhances adaptation after bowel resection. 177 Subcutaneous administration of recombinant IL-11 in rats undergoing placement of a defunctionalized (Thiry-Vella) loop of intestine or massive small bowel resection has resulted in prevention of mucosal atrophy in the defunctionalized loop and enhanced mucosal adaptation and absorptive function in the remaining intestine after resection. 4, 68 A tremendous amount of investigation has been performed to define the role of NO in the pathogenesis of a number of different inflammatory processes. There is evidence to support a possible dichotomous function of NO as both a beneficial and a detrimental molecule, especially with regard to the GI tract. 159, 161 NO is produced from arginine by three isoforms of nitric oxide synthase (NOS). NOS-1 (neuronal, nNOS) and NOS-3 (endothelial, eNOS) are constitutively present at low levels in the small intestine. NOS-2 (inducible, iNOS) is a form that can be induced in response to inflammatory cytokines. 5, 211 The constitutive forms of NOS and constitutive levels of NO have been demonstrated to modulate a number of important functions in the GI tract, including maintenance of mucosal integrity, regulation of mucosal permeability and blood flow, regulation of motility, and inhibition of leukocyte adhesion and activation. 6, 18, 90, 198, 279 Inhibition of NO synthesis in a variety of animal models of intestinal injury induced by ischemia-reperfusion, LPS, or PAF has resulted in marked exacerbation of mucosal injury. 41, 117, 158, 181, 193, 239 Administration of exogenous sources of NO, including L-arginine, sodium nitroprusside, and nitroglycerin, greatly attenuates these detrimental effects. 3, 69, 95, 228 In a prospective study of 53 premature infants, Zamora et al. 317 demonstrated a significantly lower plasma arginine level at the time of diagnosis in infants in whom NEC developed than in controls. In a randomized prospective placebo-controlled study of VLBW infants assigned to receive either daily oral or parenteral L-arginine supplements (261 mg/kg) or placebo for the first 28 days of life, Amin et al. 8 found a significantly lower incidence of NEC in the supplement group (6.7%) than in the control group (27.3%). Throughout the study, the group that received arginine supplementation had significantly higher mean plasma arginine levels than the control group did. Interestingly, in both groups the infants in whom NEC developed had significantly lower plasma arginine levels at the time of diagnosis than their respective peers did. It is not known whether the decreased arginine levels represent increased utilization for NO production, consumption for the synthesis of other proteins, or decreased enteral absorption. This study suggests the possible benefits of arginine supplementation and potentially other NO donors in the prevention of NEC.

The inducible form of NO synthase (NOS-2, iNOS) is known to be up-regulated in response to inflammatory cytokines. Within several hours of stimulation, NOS-2 expression and activity within the intestinal epithelium increase up to 15-fold and result in the production of large amounts of NO. 287 Although the low levels of NO produced by the constitutive isoforms of NOS may play a homeostatic role in the GI tract, sustained release of NO as a result of up-regulation of NOS-2 has been suggested to have deleterious effects by inducing cellular injury and failure of the mucosal barrier. 53, 60, 287 This is thought to occur by the reaction of excess NO with superoxide (O 2 − ) to produce peroxynitrite (ONOO − ), which is a potent reactive nitrogen intermediate that may trigger cytotoxic processes, including lipid peroxidation and DNA damage. 60, 242, 256 In a prospective study investigating NOS-2 expression in the intestine of infants undergoing resection for NEC, Ford et al. 84 demonstrated marked up-regulation of NOS-2 gene expression in the intestinal epithelium and increased apoptosis of enterocytes in the apical villi. In addition, increased levels of nitrotyrosine residues were detected in the apical villi, thus suggesting that the mucosal injury and increased apoptosis were mediated through the formation of NO and peroxynitrite. In a neonatal rat hypoxia model of NEC in which breast milk-fed animals were compared with formula-fed animals, Nadler et al. 208 demonstrated a significantly higher incidence of NEC, NOS-2 expression, and enterocyte apoptosis and decreased IL-12 mRNA in the formula-fed group than in the breast milk-fed group. The decreased IL-12 expression is thought to be mediated by NO and theorized to contribute to intestinal injury by attenuating bacterial clearance.

PAF, an endogenous phospholipid inflammatory mediator, has been shown to play an important role in the pathophysiology of intestinal injury in animal and human studies. 44 PAF has diverse biologic effects, including mesenteric vasoconstriction, capillary leakage, increased intestinal mucosal permeability, and neutrophil and platelet activation. 105, 160, 274 Clinically, increased PAF levels have been demonstrated in formula-fed premature infants, as well as those in whom NEC developed. 107, 182 In a neonatal rat model of NEC, Caplan et al. 39 have shown that intestinal PAF concentrations, intestinal phospholipase A 2 (PAF-synthesizing enzyme) mRNA expression, and intestinal PAF receptor mRNA expression are elevated. In other animal experiments, exogenous PAF administration results in severe bowel necrosis 94 ; endogenous intestinal production of PAF is up-regulated in response to various stimuli, including LPS, hypoxia, and TNF-α 48, 79, 116, 284 ; and administration of PAF receptor antagonist, or PAF acetylhydrolase (PAF-degrading enzyme), reduces the risk for NEC. 40, 45, 79 In human studies, PAF acetylhydrolase activity has been demonstrated to be present in human breast milk; it has been shown to be decreased in neonates, with levels approaching adult enzyme activity at around 6 weeks of life, and has been found to be deficient in infants with NEC. 42, 47, 206 In a prospective study of 164 infants at risk for NEC, Rabinowitz et al. 241 monitored serial plasma levels of PAF and PAF-related lipids (PAF-LL) to investigate the changes that occur with NEC. There was a significantly higher peak in PAF-LL levels in infants in whom NEC developed than in controls. In addition, rising PAF-LL levels were positively correlated with progression of the severity of NEC; these levels returned to baseline levels during recovery.

TNF-α has many proinflammatory effects, including neutrophil activation, induction of leukocyte and endothelial adhesion molecules, and induction of other cytokines, such as PAF. 121, 300 TNF-α has been demonstrated to produce profound hypotension and severe intestinal necrosis similar to NEC in animals. This effect has been shown to be mediated by PAF and attenuated by PAF receptor antagonists. 284 LPS (endotoxin) is a bacterial product that has the capacity to produce potent inflammatory responses through the induction of various proinflammatory cytokines such as PAF and TNF. Systemic injection of LPS has been shown to produce hypotension, shock, and severe intestinal necrosis. 115 It has been used in animal models of NEC to reliably generate intestinal injury that resembles NEC. LPS-induced intestinal injury has been demonstrated to be mediated by PAF and TNF-α and can be prevented with PAF antagonists. 116 Cyclooxygenase (COX) catalyzes the rate-limiting step of arachidonic acid metabolism into prostaglandins, leukotrienes, and thromboxanes. 212 Two isoforms of the COX enzyme have been identified. COX-1 is constitutively expressed in many tissues, including the GI tract. 308 COX-2 is the inducible form that is expressed in inflammatory conditions of the GI tract such as inflammatory bowel disease. 11, 270 Proinflammatory cytokines (IL-1, IL-6, TNF-α), as well as the proinflammatory transcription factor nuclear factor-κB (NF-κB), have been shown to increase COX-2 expression. 266 NF-κB is an important protein in the activation of a number of inflammatory mediators and cytokines. 189 A marked increase in COX-2 expression has been demonstrated in intestine resected from infants with severe NEC. 55 To elucidate the mechanisms involved in COX-2 expression in NEC, Chung et al., 55 in a neonatal rat model of NEC, demonstrated a coordinated induction of NF-κB activation and COX-2 expression during the early phase of the injurious event.

Despite many years of extensive investigation and identification of several risk factors, the pathogenesis of NEC remains elusive. The etiology is probably multifactorial and involves some combination of mucosal compromise, pathogenic bacteria, and feedings that in a susceptible host result in bowel injury and an inflammatory cascade. Of the risk factors, prematurity is the most consistent and important. Another important risk factor involves enteral feeding of formula. Commercially available formulas lack many of the beneficial properties present in breast milk. These protective agents include gut trophic hormones, factors that induce intestinal maturation, factors that enhance colonization by nonvirulent bacteria, anti-inflammatory mediators, vitamins and other antioxidants, and components that provide cellular and humoral immunity. 34, 38, 92, 104 Evidence for an Impaired Gut Barrier

The preterm GI tract is characterized by an immaturity of cellular and humoral immunity, 32,278 increased permeability, 294 reduced gastric acid secretion, 12 reduced concentration of proteolytic enzymes, 293 incomplete innervation and decreased motility, 19, 23 and immaturity of the intestinal epithelium and microvilli. 225 Decreased barrier function is evident in otherwise healthy preterm infants by their ability to systemically absorb and deliver undigested macromolecules, whole bacteria, and LPS. 91, 247, 303 Compromise of the intestinal epithelial mucosal barrier appears to be the first event leading to activation of the inflammatory cascade.

Reduced mucosal blood flow leading to cellular hypoxia and injury is one of the most frequently cited etiologic factors for NEC. Touloukian 290 emphasized the high incidence of perinatal physiologic stressors that may primarily or secondarily cause intestinal ischemia. Chief among these factors are hypoxic and hypotensive episodes, exchange transfusions through the umbilical vein, umbilical artery catheters, cardiovascular lesions, and serum hyperviscosity. An atavistic "diving reflex" in which blood is preferentially diverted away from the splanchnic circulation in order to maintain adequate perfusion of the heart and brain has been hypothesized to occur during these episodes. 216 During periods of low blood flow and subsequent reperfusion, Parks et al. 227 found that a reaction between xanthine oxidase, hypoxanthine, and molecular oxygen results in a burst of superoxide radical production. These free radicals may cause damage to cellular and mitochondrial membranes and alter the permeability of the intestinal mucosal barrier. Although animal studies provide support for this theory, clinical correlation has been lacking, and prospective clinical trials have not been able to consistently establish an association between a hypoxic event and the development of NEC. 145 Extensive investigation into the critical role of various inflammatory mediators in the pathogenesis of NEC has been conducted. Studies in animal models and human specimens have identified PAF, LPS, NO, and TNF-α as potential mediators of the disease. 48, 84, 94 The effects of LPS and TNF-α have been shown to be mediated by PAF. Increased mucosal permeability and susceptibility allowing translocation of bacteria or bacterial toxin and activation of the inflammatory cascade are thought to be the critical steps leading to the final collapse of intestinal epithelial integrity. 654, 167 Very little is known about the early chain of events that occur at the onset of tissue damage. Recent studies have suggested that the disruption in the intestinal mucosal barrier results from accelerated apoptosis. All of the key mediators identified in NEC (PAF, NO, LPS, TNF-α) have been shown to cause apoptosis of intestinal epithelial cells. 58, 84, 119, 314 In a neonatal rat model of NEC involving formula-fed animals exposed to hypoxia and cold stress and mother-fed controls, Jilling et al. 123 demonstrated a marked increase in apoptosis in the epithelial layer of the NEC group in comparison to controls, although the mechanism was undetermined. The accelerated apoptosis was shown to precede gross morphologic changes in the intestinal epithelium. Administration of a pan-caspase inhibitor to inhibit intestinal apoptosis resulted in a significantly reduced rate of epithelial apoptosis, as well as a decreased incidence of NEC, thus suggesting that apoptosis was the underlying cause of the subsequent mucosal damage ultimately leading to NEC.

Sustained overproduction of NO because of upregulation of NOS-2 in the GI tract in response to an inflammatory stimulus has been suggested to induce cellular injury and disruption of the intestinal epithelial barrier by production of the potent oxidant peroxynitrite. 53 Ford et al. 84 demonstrated up-regulation of NOS-2 and NO in the intestinal wall of infants with NEC and increased apoptosis of enterocytes mediated by the peroxynitrite. This accelerated apoptosis is thought to result in a "bare area" at the villus tip representing a break in the intestinal mucosal barrier where bacteria may attach, translocate, and initiate an inflammatory cascade. 236 In addition, peroxynitrite has also been shown to inhibit the proliferation of intestinal epithelial cells in rat models of NEC. 237 The data suggest that in conditions associated with sustained overproduction of NO or peroxynitrite (e.g., NEC), intestinal epithelial barrier dysfunction may result from an imbalance caused by accelerated epithelial injury and blunted tissue repair mechanisms.

The type of feeding and pattern of intestinal colonization may determine the risk for development of NEC. Breastfeeding infants become colonized predominantly with bifidobacteria (gram-positive bacteria), which help control the growth of gram-negative bacteria. 139, 315 In contrast, formulafed infants become colonized predominantly by coliforms, enterococci, and Bacteroides species. 140 The importance of bacteria in the pathogenesis of NEC is supported by the following evidence: (1) NEC occurs in episodic, epidemic waves, affected patients were related in place and time or had the same infectious agent, and the initiation of infection control measures has been shown to stop epidemics 26,31 ; (2) during clustered occurrences, the identical microorganisms can be isolated from both afflicted babies and their caretakers 109 ; (3) NEC can occur in infants with no known risk factors; (4) NEC can develop several weeks or months after a perinatal insult, when the GI tract is fully colonized and has had sufficient time to recover from any perinatal insult 148, 154 ; (5) administration of large doses of vitamin E (interferes with intracellular killing of bacteria by leukocytes) to premature infants has been linked with an increase in the incidence of NEC 124 ; (6) an NEC-like disease occurs in vulnerable hosts after the ingestion of Clostridium species 169 ; (7) lesions resembling NEC can be reproduced experimentally with the administration of LPS 47 ; (8) endotoxemia is demonstrated in 80% of those with NEC and positive blood cultures for gramnegative bacteria 263 ; and (9) pneumatosis intestinalis is a common radiographic finding and represents submucosal gas collections produced by bacterial fermentation. 33, 78 

The following common clinical scenario supports a unified hypothesis for the pathogenesis of NEC. A premature infant is admitted to the NICU, usually for treatment of

Necrotizing Enterocolitis respiratory distress, and is exposed to the potentially pathogenic nosocomial flora. The infant may experience intermittent episodes of apnea and bradycardia. The broadspectrum antibiotics that are routinely administered eliminate the infant's anaerobic flora, which normally functions as a barrier to colonization and overgrowth of potentially pathogenic gram-negative organisms. Instead of breast milk, formula feedings are usually administered. Formula provides substrate for bacterial growth and contains none of the protective factors present in breast milk. Poor peristalsis of the GI tract permits overgrowth by pathogenic bacteria. Depending on the quantity and virulence of the microorganisms and the presence or absence of mucosal damage, bacteria may breach the mucosal barrier. Because of deficiencies in both specific and nonspecific immune defenses, bacterial killing is ineffective. Either through episodes of decreased perfusion and reperfusion or through mild infection, the mucosal barrier is damaged. Proinflammatory cytokines are induced and result in initiation of the inflammatory cascade. This cascade leads to increased mucosal permeability, which in turn causes further damage to the mucosa and bowel wall. More bacteria and bacterial by-products invade through the mucosal breaks, and progressive bowel damage results in fullthickness necrosis and perforation.

NEC may involve single (50%) or multiple (discontinuous) segments of intestine, most commonly in the terminal ileum, followed by the colon. 15 Involvement of both the large and small intestine occurs in 44% of cases. Paninvolvement (pan-necrosis, NEC totalis) is a fulminant form of NEC characterized by necrosis of at least 75% of the gut, and it accounts for 19% of all cases of surgically treated NEC and most of the deaths. 254 At surgery, the gross appearance of NEC is fairly constant. The bowel is markedly distended with patchy areas of thinning. The serosal surfaces are typically red to gray and may be covered by a fibrinous exudate. With frank gangrene, the serosal surface is black. Subserosal gas collections are frequently encountered. The mucosal surface may be ulcerated with wide areas of epithelial sloughing. Bloody peritoneal fluid is seen when bowel necrosis is present, and brown and turbid fluid is seen when perforation has occurred.

Bowel inflammation is nearly ubiquitous in NEC (Fig. 92-1A) . The degree and nature, however, vary from one area to another. Acute and chronic inflammatory changes coexist in 60% of cases. The most common microscopic lesion is bland or coagulation necrosis of the superficial mucosa (89%). 133 Edema and hemorrhage of the submucosa follow complete mucosal necrosis (Fig. 92-1B) . Pneumatosis intestinalis is initially seen in the submucosa and later in the muscularis and subserosa. Bacteria in the bowel lumen and wall are present in up to 40% of cases and are occasionally found in gas cysts. Transmural necrosis, characterized by hyaline eosinophilia and loss of nuclear detail in the muscular layers, is present in advanced disease. Epithelial regeneration, formation of granulation tissue, and early fibrosis are often present.

This suggests a suppurative process lasting at least a few days. Granulation tissue with mucosal and submucosal fibrosis may be seen adjacent to areas of active mucosal and submucosal necrosis and may account, in part, for late stricture formation. Thrombi are sometimes noted in small mesenteric vessels and in small arterioles of the submucosa. Small-vessel thrombosis within necrotic tissue is considered a secondary change. Large-vessel thrombosis is a relatively rare finding at autopsy.

NEC is commonly heralded by nonspecific clinical findings that simply represent physiologic instability. 52 These findings include lethargy, temperature instability, recurrent apnea, bradycardia, hypoglycemia, and shock. More specific symptoms related to the GI tract include abdominal distention (70% to 98%), blood per rectum (79% to 86%), high gastric residuals after feeding (>70%), vomiting (>70%), and diarrhea (4% to 26%). Gross blood in the stool is present in 25% to 63% of cases and occult blood in 22% to 59%. Rectal bleeding is seldom massive.

Because the spectrum of disease severity varies, physical examination may initially demonstrate only subtle abdominal distention and minimal tenderness. As the disease progresses, abdominal palpation may elicit tenderness and demonstrate palpable bowel loops, a fixed or mobile mass, or abdominal wall crepitus. Edema and erythema of the abdominal wall as a result of the underlying peritonitis are present initially in approximately 4% of cases, but are more common later in the course of the disease. In males, there may be discoloration of the scrotum, indicative of perforation. In a small subset of patients, the disease is rapidly progressive and the initial manifestation is heralded by florid clinical findings and death within 24 hours.

Infants with NEC usually have neutropenia, thrombocytopenia, and metabolic acidosis. The total leukocyte count may be elevated, but it is generally low. In one study, 37% of infants had absolute neutrophil counts less than 1500 cells/mm 3 . 118 The infants with the lowest counts in this study had the worst prognosis. Neutrophil counts less than 6000 cells/mm 3 are most commonly associated with concomitant gram-negative septicemia.

Thrombocytopenia is nearly universally present and seems to be associated with gram-negative sepsis and platelet binding by endotoxin. The incidence of thrombocytopenia in NEC is 65% to 90%, essentially unchanged from the earliest reports from the 1970s. 118, 275 O'Neill 219 demonstrated that in a cohort of 40 infants who underwent surgery for NEC, 95% had platelet counts less than 150,000 cells/mm 3 . Rowe et al. 251, 253 found that platelet counts less than 150,000 cells/mm 3 were present in patients who had positive cultures for gram-negative organisms. The nadir platelet count during the course of the disease was noted to be lower in patients with more severe disease and in those who died. 299 A platelet count less than 10 9 /L or a rapid fall is a poor prognostic indicator.

Metabolic acidosis is very common (40% to 85% of patients with NEC) and is believed to result from hypovolemia and sepsis. It is not a specific indicator of intestinal necrosis. Stool samples are commonly positive for occult blood and reducing substances. Book et al. 30 reasoned that intestinal mucosal damage from NEC leads to carbohydrate malabsorption. Poorly digested carbohydrates pass into the colon where they are fermented and excreted in stool. The authors tested the stool of formulafed infants for reducing substances with Clinitest tablets and found that 71% of formula-fed infants in whom NEC developed had greater than 2+ reducing substances in their stool. Colonic bacterial fermentation increases the local production of D-lactate, which is absorbed and excreted by the kidneys. Garcia et al. 86 could show elevated urinary D-lactate levels in infants with NEC but not in control infants. With recovery from NEC or administration of enteral antibiotics, D-lactate excretion decreased. Similarly, hydrogen excretion in the breath is elevated when fermentation is increased. This test is helpful in ruling out NEC. A negative result on a breath hydrogen test is 99% accurate in ruling out NEC. 54 C-reactive protein (CRP), an acute phase reactant, has been measured in an attempt to correlate its level with the presence, absence, or resolution of the disease. 120 CRP may serve as an early indicator of NEC when its level rises more than 10 mg/L within 48 hours of the suspected diagnosis (reported sensitivity, 92%; specificity, 81%). Failure of CRP to return to normal within 10 days was an indicator of abscess, stricture, or septicemia.

It has proved extremely difficult to identify common offending infectious agents. Organisms recovered from the blood and stool of patients with NEC vary depending on the GI tract flora, the nosocomial flora, the site cultured, and the duration of previous antibiotic therapy. It is unclear whether the bacteria cultured represent pathogens causing NEC or, instead, secondary opportunistic invaders selected by the antibiotic regimen. Furthermore, lack of sufficiently matched controls and complete bacteriology data on other patients in similar environments makes study of the microbiology of NEC difficult.

Bacteriologic data for NEC have primarily been based on cultures obtained from the blood, stool, and peritoneal cavity. Blood cultures are positive in 30% to 35% of patients. 140 

In contrast to bacteria, no data implicate a fungus as an initiating organism in the pathogenesis of NEC. Fungi are believed to be secondary invaders. In 1991, the National Institute of Child Health and Human Development Neonatal Research Network study of NEC reported that 5% to 17% of blood cultures were positive for fungus. 293

Necrotizing Enterocolitis

In 1993, Karlowicz 135 reported an increase in fungal peritonitis from 7% in 1980 to 1989 to 35% in 1989 to 1991 at the same institution. Fungal septicemia with Candida species has been implicated in many late NEC deaths. 272 In a retrospective premortem and postmortem examination of body fluid and tissue cultures from 30 patients who died of NEC by Smith et al., 47% of patients had evidence of fungus. 272 Colonization was found in 20%; the first positive culture was obtained a mean of 22 ± 8.9 days after surgery. Eight patients (27%) had fungal sepsis: seven with Candida species and one with Torulopsis species. The first positive fungal culture was obtained 16.5 ± 7.0 days after surgery. Fungal sepsis was diagnosed before death in only four of the eight patients.

Mucosal injury may be mediated by toxin in some cases of NEC. 259 Toxins produced by C. difficile, C. butyricum, and E. coli have been isolated from stool samples during epidemics. Studies by Scheifele et al. 260, 261 have demonstrated that a delta toxin is elaborated from coagulasenegative staphylococci and is present in the stool of 56% of coagulase-negative staphylococcal cases of NEC. This toxin is rarely found in patients colonized with coagulasenegative staphylococci without NEC.

In most large series, sporadic cases have been followed by the sudden appearance of a cluster of a relatively large number of cases. In many of the epidemics, no specific pathogen has been identified. Book et al., 31 as part of an ongoing nosocomial infection surveillance program, prospectively studied 74 infants in whom NEC developed between 1972 and 1977. Six temporally and geographically related clusters of cases of NEC occurred, and no specific organisms were isolated. During these episodes, nursery personnel experienced concomitant acute GI illnesses. Implementation of infection control measures was associated with a significant decrease in the rate of NEC. Similar epidemics without specific pathogens were noted at Rainbow Babies and Children's Hospital in 1972, 1973, 1974, 1975, and 1978. 140 At the Children's Hospital of Philadelphia, 199 11 sporadic cases of NEC occurred, but no pathogen was identified in the stools of infants in the nursery. Van Acker et al. 295 reported an outbreak of NEC in 12 infants over a 2-month period associated with Enterobacter sakazakii. This pathogen was found to be a contaminant of the powdered milk formula that was used in the NICU. Other epidemic outbreaks have identified E. coli, Salmonella species, C. difficile, rotavirus, and a coronavirus-like organism. 26, 259 

The cornerstone of the diagnosis of NEC is plain anteroposterior and left lateral decubitus radiographs. Any or all of the following findings are associated with NEC: ileus pattern (nonspecific bowel distention), pneumatosis intestinalis (linear or cystic) (Fig. 92-2) , portal vein gas, pneumoperitoneum, intraperitoneal fluid, and persistently dilated, fixed loops. 204 Both pneumatosis and portal vein gas are often fleeting signs.

Multiple gas-filled loops of intestine are the earliest and most common radiologic finding in patients with NEC (55% to 100% of cases). 62 As fluid and air accumulate, airfluid levels are visible on the decubitus view. The degree of dilatation and the distribution of bowel loops are related to the clinical severity and progression of the disease. In some cases, nonspecific intestinal dilatation precedes clinical symptoms suggestive of NEC by several hours.

Demonstration of pneumatosis intestinalis (intramural gas) in the appropriate clinical setting is diagnostic of NEC. The air mainly comprises hydrogen, a by-product of bacterial metabolism. The frequency of pneumatosis intestinalis ranges from 19% to 98%, although it may be absent in up to 14% of patients with NEC (even severe disease). 143 Conversely, extensive pneumatosis may be present with minimal signs; it often responds promptly to medical management.

Pneumatosis is fleeting, may appear before the onset of clinical symptoms, and is commonly an early rather than a late finding. It is most frequently noted when infants have been fed (84%), in contrast to unfed babies (14%). 185 Pneumatosis intestinalis is not specific for NEC and has been noted in infants with enterocolitis of Hirschsprung's disease, inspissated milk syndrome, pyloric stenosis, severe diarrhea, carbohydrate intolerance, and other disorders.

Two forms of pneumatosis intestinalis are recognized radiographically: cystic and linear. The cystic form has a granular or foamy appearance and represents gas in the submucosa. It is often confused with fecal material in the large intestine. Linear pneumatosis consists of small bubbles collected within the muscularis and subserosa to form a thin linear or curvilinear gas pattern outlining the wall of a segment of the intestine.

Portal vein gas appears as linear branching radiolucencies overlying the liver and often extending to its periphery. It represents gas dispersed through the fine radicles of the portal venous system. The presence of portal vein gas is fleeting, which perhaps accounts for the low reported incidence of 10% to 30%. 35 In most series, the presence of portal vein gas is associated with a poor prognosis. 143 In cases with pan-involvement, the gas is present in 61% of patients. The genesis of portal vein gas may involve accumulation of gas in the bowel wall as a result of bacterial invasion, dissection into the venous system, and migration to the radicles of the portal vein. Alternatively, it may represent the action of gas-forming bacteria within the portal venous system.

Free air in the peritoneal cavity associated with perforation of the intestine can be demonstrated in 12% to 30% of patients. It is best noted on the left lateral decubitus or cross-table lateral view. Upright radiography is unnecessary. A supine view of the abdomen can demonstrate free air by outlining the falciform ligament ("football sign"), the umbilical artery, or urachal remnants or by revealing the "double wall" sign. This sign refers to visualization of air on both sides of the wall (lumen and peritoneal cavity). In patients who have intestinal perforation proved by surgery, radiographic evidence shows free air in only 63%, thus demonstrating that perforation can occur in a surprisingly high number of patients without evidence of free air.

One must keep in mind that pneumoperitoneum may occur without intestinal perforation from mechanical ventilation for severe lung disease. In this clinical situation, barotrauma may produce alveolar rupture with air dissection into the abdomen through the mediastinum. The patient's signs, symptoms, and laboratory findings will often differentiate the cause of the air. If one is unsure, abdominal paracentesis may be performed and any aspirated fluid analyzed. If there is no ascites, a watersoluble contrast study via the gastric tube may be performed to rule out gastric perforation.

Several plain radiographic findings suggest free fluid in the peritoneal cavity that is amenable to paracentesis: (1) a grossly distended abdomen devoid of gas, (2) gas-filled loops of bowel in the center of the abdomen surrounded by opacity out to the flanks, (3) increased haziness within the abdomen, and (4) separation of bowel loops. These findings have been reported in 11% of cases. Both ascites and portal vein gas are radiographic findings associated with high mortality rates. Twenty-one percent of patients with surgically proven intestinal perforation have ascites. However, 16% of all patients with proven intestinal perforation have neither ascites nor free air on plain radiographs.

The "persistent dilated loop sign" is a plain radiographic finding that was described by Wexler 305 in a study of five babies with NEC in whom a single loop or several loops of dilated bowel remained unchanged in position and configuration for 24 to 36 hours. Full-thickness necrosis subsequently developed in these patients. This finding, however, does not always indicate bowel necrosis. Leonard et al. 175 found a persistent loop in 33% of 21 patients with proven NEC. Fifty-seven percent of infants with a persistent loop had necrotic intestine at surgery or autopsy, but necrosis never developed in 43% and they recovered with nonoperative treatment.

Radiopaque contrast studies of the upper GI tract may occasionally be useful to improve diagnostic accuracy in patients with equivocal clinical and radiologic signs of NEC. However, overdiagnosis by contrast radiography is possible and may lead to unwarranted treatment. Careful attention to the type of contrast agent used for the study is critical. 305 Barium should never be used because extravasation of a barium and stool mixture through a perforation may intensify the peritonitis. Unlike barium, water-soluble contrast agents are absorbed by both the bowel and the peritoneal cavity. The practical implication of this absorption is a transient (6 to 12 hours) increase in urinary specific gravity. Historically, watersoluble agents were hyperosmolar and caused dangerously large intraluminal fluid shifts, especially in premature patients. Current water-soluble agents are nonionic, have much lower osmolarity, and produce excellent opacification of the GI tract. NEC is suspected when intestinal contrast enhancement demonstrates bowel wall loops separated by edematous walls, an irregular mucosa with ill-defined margins, mucosal ulceration, bowel wall spiculation, or pneumatosis intestinalis. The examination may be performed at the bedside.

Though advocated by some, 134 contrast enemas should not be performed because of the risk for rectosigmoid perforation. Unless there is colonic disease or reflux of

Necrotizing Enterocolitis contrast into a diseased distal ileum, the contrast enema will not be diagnostic of NEC. It may, in fact, overdiagnose NEC because contrast enemas have been shown to produce pneumatosis and transient portal venous air. Unlike the bedside upper GI series, contrast enema must be performed with simultaneous fluoroscopy, which necessitates transfer of the critically ill neonate to the radiology suite. In an infant who has recently completed a course of therapy for NEC but signs of partial small bowel obstruction or blood-tinged stools develop, contrast enemas are very useful in identifying strictures.

Ultrasonography (US) has been used to identify necrotic bowel, intraperitoneal fluid, and portal venous air. Theoretically, US may have significant value if it can identify patients who require surgery in a more sensitive and timely manner than is possible with conventional clinical and radiographic methods.

Abnormal bowel loops on US are characterized by a hypoechoic rim with a central echogenic focus ("target sign"). 150 Pericholecystic hyperechogenicity, believed to represent either pericholecystic venous gas or extension of the foamy inflammatory infiltrate of NEC into the pericholecystic space, was described by Avni et al. 13 The use of US for the diagnosis of NEC is most applicable to patients with questionable clinical and radiologic findings or to localize intra-abdominal fluid for paracentesis.

Magnetic resonance imaging (MRI) is a noninvasive modality that has recently been used to identify infants with ischemic bowel secondary to NEC. Although MRI is capable of demonstrating the cardinal findings of NEC, the need to use this study is limited at most. 180

To select the appropriate treatment (nonoperative versus operative) and to determine the impact of therapy on survival and late outcome, it is essential that investigators use comparable criteria for classifying the stages of NEC. Several classification schemes have been proposed. In 1978, Bell et al. 21 introduced the now most commonly used classification, a three-stage system (suspected, definite, and advanced) that categorizes patients by historical factors, GI manifestations, radiologic findings, and systemic signs (Table 92 -2). The Bell staging criteria have been modified 148 ; the three stages are still used, but subsets are included in an effort to identify specific prognostic factors. Infants with stage I disease have features suggestive of NEC, patients with stage II disease have definitive NEC without an indication for surgical intervention, and patients with stage III disease have advanced NEC with evidence of bowel necrosis or perforation.

In the absence of intestinal necrosis or perforation, the mainstay of treatment for patients with NEC is supportive. Feedings are stopped, the GI tract is decompressed through a sump gastric tube, and intravenous fluid resuscitation is initiated. A complete blood count, platelet count, blood gas analysis, and CRP and serum electrolyte levels are obtained. Blood and urine samples are sent for culture, and broadspectrum intravenous antibiotic therapy is initiated. Until recently, most antibiotic regimens included a penicillin, an aminoglycoside, and an agent effective against anaerobic organisms. It seems logical that coverage for anaerobic organisms be included because these infants are usually 1 to 2 weeks old, but in carefully performed studies, anaerobes are sparse. To date, no controlled study has shown the efficacy of this therapy. The antibiotic regimen is best tailored not only to the most common organisms found with NEC but also to the nosocomial nursery flora. Because of recent reports of patients with stool and blood cultures positive for coagulase-negative staphylococci, some groups now empirically treat patients with a combination of vancomycin and gentamicin or vancomycin and a third-generation cephalosporin. 262 The incidence of fungal sepsis in infants who die of NEC is high, so a strong index of suspicion must be maintained and empirical antifungal therapy should be considered if the patient continues to be symptomatic without an obvious bacterial cause. Close clinical observation consists of frequent physical examination, two-view abdominal radiography performed every 6 to 8 hours, serum platelet and leukocyte counts, and blood gas analysis.

Once feedings resume, stools are tested for reducing substances and occult blood. Feedings are discontinued if the result of either test becomes positive. Patients with definite disease of moderate severity (Bell stage II) are treated by bowel rest, decompression, and antibiotic therapy for at least 7 to 14 days. A central venous catheter may be placed for total parenteral nutrition. If the patient is clinically well, small amounts of diluted formula may be restarted. The infant is constantly and carefully monitored for abdominal distention, vomiting, or nonspecific signs or symptoms of NEC. Feedings are progressed slowly to goal volumes while avoiding the use of concentrated formulas or large-volume feeding. Infants who have undergone surgery receive 1 to 2 weeks of postoperative intravenous antibiotics. Feedings are initiated when the patient is clinically well and return of bowel function has been established.

The principal goals of surgical intervention in the setting of NEC are to remove gangrenous bowel and preserve intestinal length. 81, 229 Ideally, surgery should not be undertaken until gangrene is present but be performed before perforation occurs. Unfortunately, no combination of clinical examination or adjunct testing has been shown to have high sensitivity for intestinal gangrene. 153, 155 Thus, there remains controversy regarding the indications for surgery, the most appropriate timing of intervention, and the optimal surgical treatment strategy. The most widely accepted indication for surgery is the presence of pneumoperitoneum. In an attempt to identify characteristics that may serve as predictors of intestinal gangrene, Kosloske 153 reviewed 12 criteria used as indications for surgery in 147 patients with NEC and stratified these criteria according to sensitivity, specificity, positive/negative predictive value, and prevalence. The "best" indicators (specificity and positive predictive value [PPV] approaching 100%, prevalence >10%) were pneumoperitoneum, positive paracentesis (aspiration of >0.5 mL brown or yellow fluid containing bacteria on Gram stain), and portal venous gas. "Good" indicators (specificity and PPV approaching 100%, prevalence <10%) were a fixed intestinal loop, erythema of the abdominal wall, and a palpable abdominal mass. A "fair" indicator (specificity of 91%, PPV of 94%, prevalence of 20%) was "severe" pneumatosis intestinalis as graded by a radiographic system. "Poorer" indicators were clinical deterioration (PPV of 78%), platelet count lower than 100,000/mm 3 (PPV of 50%), abdominal tenderness (PPV of 58%), severe GI hemorrhage (PPV of 50%), and gasless abdomen with ascites (0%). Unfortunately, none of the indicators had sensitivity greater than 48%. Currently, the only absolute indication for surgery is pneumoperitoneum. Relative indications include a positive paracentesis, palpable abdominal mass, abdominal wall erythema, portal venous gas, fixed intestinal loop, and clinical deterioration despite maximal medical therapy.

Infants in whom pneumoperitoneum develops during nonoperative treatment should undergo either laparotomy or peritoneal drain placement. Unfortunately, pneumoperitoneum is not always demonstrable in neonates with gut perforation, with one study reporting that only 63% of infants with perforation demonstrated free air. 85 Paracentesis A positive result on paracentesis, defined as free-flowing aspiration of more than 0.5 mL of brown or yellow-brown fluid that contains bacteria on gram stain, 53 is highly specific for intestinal necrosis. A negative result on paracentesis is rare with intestinal necrosis but can occur when a localized, walled-off perforation is present or a segment of bowel is injured but not perforated. 246 There is no absolute indication for paracentesis. Kosloske 153 recommends abdominal paracentesis for patients with extensive pneumatosis intestinalis or for those who do not improve with nonoperative management. If no peritoneal fluid is aspirated, peritoneal lavage is performed by instilling up to 30 mL/kg of normal saline solution into the peritoneal cavity, turning the patient from side to side, and then withdrawing the fluid. Ricketts and Jerles 246 reported a greater than 70% survival rate when a positive result on abdominal paracentesis was used as the indication for surgery in 51% of their patients; three false negatives occurred. They performed paracentesis when there was erythema and edema of the abdominal wall, portal vein gas, a fixed and dilated loop on sequential abdominal radiography, a fixed and tender abdominal mass, or persistent clinical deterioration. The indications used for paracentesis in this report are considered indications for surgery by many surgeons.

To determine the significance of portal vein gas in relation to the presence and extent of bowel necrosis and mortality, Kurkchubasche et al. 164 reviewed the experience of Children's Hospital of Pittsburgh, as well as the world literature. Of the 616 patients collected, 118 (19%) had portal vein gas on plain radiography. Of these 118 patients, 102 underwent surgery, usually 24 hours after the radiographic appearance of portal vein gas. All 102 patients had full-thickness bowel necrosis, and 52% had necrosis of more than 75% of the length of the entire small intestine. The overall surgical mortality rate for patients with portal vein gas was 52%, and more than 90% of those with pan-involvement died. Of the 15 patients who had portal vein gas and did not undergo surgery, bowel necrosis requiring surgery developed in 6 (40%), and 5 of the 6 died. In a separate study, Rowe et al. 254 suggested that intestinal necrosis will develop in more than 90% of infants with portal venous gas, with pan-involvement developing in 52%. More recently, in a review of 40 infants with NEC and portal venous gas, Molik et al. 196 reported a 54% overall operative mortality and paninvolvement in 25%.

Necrotizing Enterocolitis

A fixed dilated intestinal loop is defined by persistent location and configuration for more than 24 hours. Approximately half the patients recover without an operation. 230 Laparoscopy has been used to assess two patients with dilated intestinal loops. 231 NEC was confirmed in one case and ruled out in the other.

There are many criteria for operating on children who show continued clinical deterioration despite adequate supportive therapy, 245 but none by themselves are absolute indications. These criteria include abdominal wall erythema, peritonitis on physical examination, persistent/increasing acidosis, and persistent/progressive thrombocytopenia.

As mentioned, pneumoperitoneum may not always be evident with intestinal perforation. A gasless abdomen, suggestive of a fluid-filled abdominal cavity, may be the only indication of perforation. Frey et al. 85 reported that in 21% of infants with intestinal perforation, the only radiographic evidence was ascites. They noted that radiographs are imprecise and that evidence of ascites in the appropriate clinical setting of NEC mandates paracentesis for further evaluation.

Advanced disease requiring surgical intervention develops in up to 50% of infants with NEC. 36, 151 Because of the lack of quality prospective randomized trials, the optimal surgical treatment strategy for NEC remains controversial. The goals of surgery are to remove gangrenous bowel and preserve intestinal length. Within this context, a number of different options exist, but most agree that the surgical approach should be determined by the extent of intestinal involvement.

The patient's general condition should be optimized before surgery with aggressive ventilatory support, treatment of shock, administration of broad-spectrum antibiotics, and correction of anemia and coagulopathy. Ideally, a minimum urine output of 1 mL/kg/hr and an ageappropriate mean arterial pressure should be achieved. Operative procedures may be performed in the NICU under appropriate conditions without an increase in complications. 87 

Treatment of intestinal perforation in VLBW infants remains controversial. In 1977, Ein et al. 77 reported the use of peritoneal drainage (PD) as a means of stabilizing and improving the systemic status of premature infants with perforation before laparotomy. Since then, primary treatment with PD has been used in a variety of settings, and some investigators have suggested that it may serve as definitive therapy. 14, 66, 93, 176, 203 In a prospective study involving 44 infants treated with PD as primary management for advanced NEC, Demestre et al. 66 reported 28 patients (63.6%) treated with PD only and 16 patients (36.4%) who required laparotomy after PD. The survival rate after PD only was 64%, although 86% demonstrated improvement after drainage. After PD, 54% of infants required delayed surgery. Morgan et al. 203 used PD as primary treatment of NEC and perforation for infants weighing less than 1500 g and for unstable babies heavier than 1500 g. They reported a 79% survival rate after PD, with 17 of 23 (73.9%) survivors requiring no other operative intervention. Moss et al. 205 recently performed a meta-analysis of PD versus laparotomy for perforated NEC and reviewed 10 published studies on this topic. Because of the marked bias in treatment assignment, with a greater proportion of smaller babies undergoing PD versus laparotomy, the authors were unable to determine the relative merits of PD. Currently, most surgeons propose PD as the initial treatment in VLBW infants with perforated NEC to allow resuscitation and stabilization before definitive laparotomy. In an attempt to address this issue, two multicenter prospective randomized controlled trials are currently in progress to compare PD with primary laparotomy in premature infants less than 1000 g (A. Pierro: NET trial) or less than 1500 g (R.L. Moss: NECSTEPS trial).

At laparotomy, the extent of NEC may be classified as focal, multifocal, or pan-intestinal (<25% viable bowel). Depending on the disease and patient characteristics at the time of surgery, a number of different surgical options may be undertaken, including resection with enterostomy, resection with anastomosis, proximal enterostomy, the "clip and drop" technique, and the "patch, drain, and wait" technique. The abdomen is entered via a right transverse supraumbilical incision with precautions taken to not injure the liver. Samples of peritoneal fluid may be harvested for culture of aerobic, anaerobic, and fungal organisms. The entire GI tract is systematically examined to assess the extent of disease and viability of the bowel. At the conclusion of the procedure, one should record the length of viable intestine remaining and note the presence or absence of the ileocecal valve.

A rarely cited complication of laparotomy for NEC is spontaneous intraoperative liver hemorrhage from injury caused by retractors or finger dissection. VanderKolk et al. 296 reported this complication in 11.8% of operations for NEC over a 5-year period. The mean gestational age of those with liver hemorrhage was 28 weeks (mean weight, 1262 g). Only one of these patients survived. The authors identified low mean preoperative arterial pressure and high preoperative fluid administration over the preceding 24 hours as significant predisposing factors. This complication occurred shortly after the abdomen was opened and the intestine was eviscerated. Liver congestion was followed by subcapsular hematoma and then free rupture.

When a single area of bowel is necrotic or perforated, only limited resection is necessary. Creation of a proximal enterostomy and distal mucus fistula has been the standard of care. We prefer to exteriorize the stomas through the wound (either juxtaposed or separated) because (1) the mesentery is often thick and foreshortened, thus making passage of the stoma and its blood supply through the abdominal wall difficult, (2) stoma closure is facilitated, and (3) the incidence of wound complications is not increased in comparison to stomas at remote locations. The enterostomy is created by suturing the intestine to the fascia with interrupted sutures. About 2 cm of bowel is left protruding from the abdominal wall, and no attempt is made to use sutures to "mature" the end of the intestine. If stoma viability is in question after surgery, a small portion of the full thickness of the intestine is excised at the bedside and the cut ends are observed for bleeding.

Resection with primary anastomosis for isolated disease may be performed in carefully selected patients. Proponents of primary anastomosis cite the high morbidity associated with enterostomies in infants and no need for a second operation. 1 To safely perform this technique, the following criteria must be met: (1) a sharply localized, usually proximal segment of disease, (2) undamaged appearance of the remaining intestine, and (3) good overall patient condition without evidence of rapidly progressive sepsis or coagulopathy.

If the patient has multiple areas of necrosis separated by viable bowel, several options are available. Historically, the surgeon excises each diseased segment individually and creates multiple stomas rather than performing a massive resection. Conversely, a single high stoma (proximal jejunum) may be created and the distal bowel "spliced" together, thereby avoiding multiple stomas. A proximal jejunostomy can cause significant fluid and electrolyte loss and peristomal skin complications, although aggressive skin care with measurement and replacement of the stoma losses can avoid these potential complications. Anastomotic strictures are not uncommon and are addressed at the time of jejunostomy closure. Resection plus anastomosis has also gained increased acceptance as a valid treatment option for severe NEC and for multifocal disease. 229 In a study involving 46 infants with multifocal NEC, Fasoli et al. 81 reported a higher survival rate after resection and primary anastomosis (85%) versus enterostomy (50%).

Moore 200 described a controversial approach termed the "patch, drain, and wait" procedure in 1989. The principles of this potentially bowel length-preserving method are transverse single-layer suture approximation of perforations (patch), insertion of two Penrose drains that exit in the lower quadrants (drain), and a commitment to longterm parenteral nutrition (wait). The Penrose drains capture fecal fistulas and function as de facto enterostomies as the peritoneal cavity is rapidly obliterated by adhesions. 201 This procedure does not address the issue of ongoing sepsis because necrotic bowel is not resected, the general peritoneal cavity is difficult to drain, and the thin-walled perforated bowel often cannot handle suture.

Vaughan et al. 298 described a promising novel technique aimed at avoiding multiple enterostomies, circumventing the complications of a high jejunostomy, and preserving bowel length. The authors performed the "clip and drop back" technique in three patients with NEC. In this procedure, the obviously necrotic bowel is removed, and the cut ends are closed with titanium clips or staples. Re-exploration is performed 48 to 72 hours later, the clips are removed, and all segments are reanastomosed without any stomas. In one of the three patients, re-resection was required during the second-look operation, the bowel ends were clipped again, and a successful primary anastomosis was performed during a third operation. Follow-up for this very small series was 6 months to 7 years with no anastomotic complications or delayed reoperations.

Pan-involvement develops in 19% of patients 164 ; it poses an enormous treatment problem and is a highly controversial management issue. The overriding consideration is to spare as much intestine as possible. Treatment options include resection of all necrotic bowel with placement of proximal or multiple stomas or proximal diversion without bowel resection, with plans for a second-look procedure. The decision to forego any treatment is supported by studies that demonstrate a 42% to 100% mortality rate in patients with pan-involvement, with almost all survivors left with short-bowel syndrome. The mortality rate is nearly 100% for infants who weigh less than 1000 g.

Diverting the intestinal stream by high proximal jejunostomy (without bowel resection) may facilitate healing of injured bowel through distal intestinal decompression, a reduction in its metabolic demands, and a decrease in the number of bacteria and possibly their by-products. This technique was initially reported by Martin and Neblett 186 and involves performing a high jejunostomy without resection, with plans for a second-look operation after 6 to 8 weeks. In a series of 10 patients with pan-involvement, Sugarman and Kiely 283 reported 8 infants surviving to undergo a second procedure. Resection of necrotic segments plus anastomosis was performed successfully, but the long-term survival rate was only 50%.

There is neither an ideal weight and age nor a universally agreed upon time at which intestinal continuity should be restored. The principal determinants are time since surgery, weight gain, and stoma output. In general, the enterostomy may be safely closed anytime after 4 weeks since the last operation, the risk period for strictures; attempted closure at less than 4 weeks after surgery may be met with a peritoneal cavity that is obliterated by vascular adhesions and resolving inflammation. Before enterostomy closure, patency of the distal end of the bowel should be confirmed by either a retrograde or antegrade contrast study. A study by Musemeche et al. 207 examined the complication rate after stomas were closed less than 3 months after surgery, 3 to 5 months after surgery, and more than 5 months after surgery; no differences were found. They also noted no difference in complications between patients who underwent closure at a body weight less than 2.5 kg, 2.5 to 5.0 kg, or greater than 5.0 kg.

Although enterostomy in neonates may be lifesaving, it is also a major cause of morbidity. In recent studies, enterostomies in newborns had an associated complication rate ranging from 34% to 68%. 217, 302 Complications included wound infections, wound dehiscence, stoma stenosis requiring revision, incisional hernia, parastomal hernia, prolapse or intussusception, and small bowel obstruction.

Over the past decades, the survival of infants with NEC has progressively improved (Table 92-3) . 250 This improvement has been attributed to earlier diagnosis and more effective supportive treatment for premature infants. Effective supportive treatment includes improved ventilatory strategies, surfactant therapy, total parenteral nutrition, improved understanding of the pathophysiology and management of critically ill newborns, and advancements in pediatric anesthesia. The increased survival has been most noticeable in infants who weigh less than 1000 g and are less than 28 weeks' gestational age. In a recent review of 754 premature infants born between 22 and 25 weeks' gestation, the overall survival rate was 63%, with a range of 14% at 22 weeks' gestation to 76% at 25 weeks' gestation. 51 Mortality was still significantly higher in VLBW infants than larger patients. This is highlighted by studies that examined the outcome of VLBW infants in comparison to "standard" premature infants (>1000 g) with pan-involvement NEC. Snyder et al. 273 found that infants weighing less than 1000 g are more likely to require surgery (51% versus 34%) and to eventually have pan-involvement (10% versus 4%) than infants greater than 1000 g. Pan-involvement was associated with 100% mortality in both groups. In a retrospective study of 70 infants weighing less than 1000 g with perforated NEC, Erhlich et al. 75 demonstrated that infant survival was independent of the type of surgical treatment (PD versus laparotomy), but instead was inversely related to the number of comorbid conditions associated with the patient.

We do not believe that the differences in mortality rates between series are attributable to differences in the effectiveness of the treatment programs used. In different groups of patients, the disease varies from predominantly localized disease to extensive necrosis. The patient population differs between the various series. The mortality rate can vary considerably, depending on birth weight, coexisting disease, virulence of the disease process, and whether the patient is in-born locally versus transferred. The precarious state of patients at risk for NEC is emphasized by the fact that in one series that compared patients who had NEC with matched controls, the mortality rate in the controls was 33%. 280

The first clinical and radiologic description of intestinal stricture after recovery from acute NEC was reported in 1968 by Rabinowitz et al. 240 The reported overall incidence varies from 9% to 36%, 114, 269 and stricture formation is more frequent after nonoperative treatment. The incidence of strictures after NEC is increasing as the mortality rate from the disease decreases. Strictures result from fibrotic healing of an area of severe ischemic injury. Regardless of whether the stricture follows operative or nonoperative therapy, the most common site of involvement has been the colon (80%). The next most common site is the terminal ileum (15%). Sixty percent of colonic strictures involve the left colon, and the most common colonic site is the splenic flexure (21%). Most patients have single strictures, but multiple strictures can occur (15%). 122 An intestinal stricture should be suspected after nonoperative management of NEC in an infant with failure to thrive, rectal bleeding, or bowel obstruction. These signs and symptoms occur in 50% of patients with strictures and should be evaluated with a contrast enema. If the study demonstrates a stricture in a symptomatic patient, elective resection with anastomosis is usually indicated. 

Cholestatic liver disease results from a number of factors, but primarily from prolonged administration of total parenteral nutrition. It is characterized by direct hyperbilirubinemia, hepatomegaly, and elevated aminotransferase levels. Although the condition is multifactorial, the most important contributing factor is probably prolonged fasting. It has been shown that the most effective treatment is establishment of early, small-volume enteral feeding, concomitant with the administration of total parenteral nutrition, which aids in bowel adaptation by conferring a trophic effect on the intestinal mucosa and by stimulating bile flow.

NEC can recur after operative and nonoperative management. The incidence is 4% to 6%. 246, 282 No consistent association has been noted between recurrent NEC and the type or timing of enteral feeding, the anatomic site, or the method of initial management. More than 70% of patients were successfully treated nonoperatively for recurrence by Stringer et al. 282 

A late complication that may occur many years after resection for NEC is the development of anastomotic ulceration. Sondheimer et al. 276 reported six children who underwent ileocolonic resection and anastomosis in the neonatal period in whom lower GI bleeding developed at 5 to 13 years of age. Anastomotic ulceration was diagnosed by colonoscopy, and treatment entailed ulcer resection in five of six patients. Recurrence of marginal ulcers developed in four of five patients who underwent resection. Histologic examination revealed shallow ulcers penetrating only to the muscularis. The cause of the ulcers is unknown.

The length of hospitalization of infants has been strongly associated with developmental progress at 1 to 2 years of age. 269 This probably reflects the adverse effects of medical and social factors on the developing brain. It is recommended that developmental screening be performed every 4 months during the first year and every 6 months during the second year because long-term follow-up data suggest that normal premature infants and survivors of severe NEC remain at high risk for neurologic developmental morbidity. Approximately 50% of infants surviving NEC are neurodevelopmentally normal. 246, 280 Historically, it was believed that any adverse neurodevelopmental outcome in a patient treated for NEC was due to underlying prematurity and comorbid conditions rather than the NEC itself, but recent evaluations of surviving infants contest this assumption. Vohr et al. 301 studied the neurodevelopmental, neurosensory, and functional outcomes of 1151 extremely low-birth-weight (401 to 1000 g) survivors at 18 to 22 months' corrected age and reported significant deficits in neurologic development (25%), a Bayley II Mental Developmental Index less than 70 (37%), a Psychomotor Development Index less than 70 (29%), vision impairment (9%), and hearing impairment (11%). NEC was specifically associated as a risk factor for both an abnormal neurologic examination and a low Bayley Psychomotor Development Index. In a study assessing the effect of NEC on neurodevelopment, Sonntag et al. 277 compared VLBW infants with NEC with matched infants without NEC at 12 and 20 months' corrected age. Despite normal somatic growth in infants with NEC not complicated by short-bowel syndrome, the authors demonstrated significant neurodevelopmental delay at both 12 and 20 months of age. Fifty-five percent of infants with NEC were noted to be severely retarded versus only 22.5% of infants without NEC.

Attempts to reduce the incidence of or prevent NEC must consider the probable pathogenesis of the disease and some of the putative perinatal risk factors. Investigations into preventive measures for NEC, including limiting the nosocomial spread of microorganisms, augmenting host defense, decreasing bacterial colonization and overgrowth in the GI tract, providing factors that enhance intestinal maturation, and attenuating the inflammatory cascade, may be useful. Infection control measures, breastfeeding, cautious feeding of sick premature babies, immunoglobulin supplementation of feedings, corticosteroid therapy, administration of growth factors, and use of inflammatory mediator antagonists are some of the preventive strategies that have been studied.

Adoption of infection control measures in the nursery may limit the incidence and restrict the spread of infections, thereby potentially eliminating the epidemic waves of NEC. The traditional prophylaxis for nosocomial epidemics includes strict hand washing with a germicidal agent, long-sleeved gown and gloves, separate diaper and laundry bags for each patient, cohorting and isolation of confirmed cases, and separate rooms and nurses for confirmed cases (without cross-covering). It has been demonstrated that the initiation of infection control measures stops epidemics of NEC. 31, 109 During clustered occurrences, identical microorganisms can be isolated from both the afflicted neonates and their caretakers.

The protective immunoglobulins, principally IgA, are deficient in the premature gut. In the absence of breastfeeding, there are only trace amounts of secretory IgA and gut-associated IgG and IgM. Secretory IgA acts as an "antiseptic paint" by binding bacteria and preventing their attachment to the intestinal mucosa. Eibl et al. 76 demonstrated that enteral administration of an IgG-IgA preparation decreases the incidence of NEC. Their randomized trial involved feeding 179 high-risk infants weighing 800 to 2000 g a human preparation of IgG and IgA with their formula, whereas controls received formula alone. Neither group received breast milk. No cases of NEC developed in the immunoglobulin group, but 6 cases developed in the 91 controls. In a recent study in rabbits, Dickinson et al. 67 demonstrated that IgA supplementation in feedings prevented bacterial translocation by enhancing gut mucosal barrier functions. This effect was not seen with IgG or lactoferrin. In a randomized double-blind controlled trial, enteral IgG supplementation in infants failed to reduce the incidence of NEC. 170 

Glucocorticoids have been shown to accelerate mucosal cell maturation and improve gut barrier function. The action is mediated by glycosylation on the intestinal surface, which impairs bacterial attachment. Glucocorticoids have also been shown to down-regulate the inflammatory response by stimulating the enzymatic degradation of PAF. 274 These observations have been made experimentally and clinically. 76, 101 Bauer et al. 20 retrospectively noted a significant reduction in the incidence of NEC in babies born to mothers who received antenatal glucocorticoids for fetal pulmonary maturation as compared with controls (2% versus 7%). This large, multicenter, placebo-controlled trial was well controlled for many potentially confounding variables. Halac et al. 101 conducted a randomized, controlled trial of prenatal glucocorticoid administration to mothers in preterm labor. The control mothers received placebo, but their infants received an immediate postnatal course of high-dose dexamethasone for 7 days. The rate of NEC within and between groups significantly decreased after prenatal and postnatal steroid treatment. Although postnatal therapy did not decrease the incidence as effectively as prenatal therapy did, it improved the clinical outcome of NEC; however, many potentially confounding factors were not assessed in this study. Confirmatory prospective data and assessment of potential postnatal toxicity are needed.

Breast milk decreases the risk for a number of neonatal infections, including lower respiratory tract illness, otitis media, bacteremia, meningitis, and NEC. 34 Human milk provides an array of humoral and cellular anti-infectious factors, growth factors, and probiotics, as well as essential vitamins and nutrients. Milk factors include IgA, macrophages, lymphocytes, components of the complement system, lactoferrin, lysozyme, transferrin, interferon, EGF, alpha fetoprotein, erythropoietin, the probiotics Bifidobacterium infantis and Lactobacillus acidophilus, PAF acetylhydrolase, and several inflammatory mediators. Strong evidence exists for the protective role of secretory IgA, the main immune component of the enteromammary axis. Breast milk also inhibits the growth of E. coli by providing an acidic environment, promoting competitive growth of Lactobacillus bifidus, and binding iron (an element essential for the growth of E. coli). 17 Because invasion by infectious agents seems to be a prime factor in the pathogenesis of NEC, breast milk appears to be ideally suited to protect the infant against the disease. Administration of breast milk prevents experimental NEC. 17, 65 Formula-fed babies have four to six times the incidence of NEC as breast-fed infants do. 179 

There is little disagreement that NEC is more common in fed infants and that bacterial overgrowth is facilitated by the substrate provided by formula. Although the potential benefit of careful regulation of feeding to prevent NEC is widely accepted, randomized trials have failed to demonstrate any difference in the incidence of NEC related to fast versus slow, early versus delayed, or continuous versus intermittent bolus feeding. 136, 137, 166, 220, 238, 243 Low-birth-weight infants and infants with illnesses or prenatal problems are not fed for 7 to 10 days. Nutrition is provided parenterally. If no symptoms suggestive of NEC develop, feedings are cautiously begun. The type, concentration, and rate of increase are not universally accepted, although most clinicians begin with a hypocaloric formula at a slow rate. Feedings are withheld and the infant is evaluated if gastric residuals increase or any clinical findings potentially associated with NEC develop.

Probiotic bacteria are defined as "live microbial supplements that colonize the intestine to provide benefit to the host." 43, 192 The use of anaerobic bacterial supplementation in the treatment or prevention of GI disease has been well described. There has been increasing interest in using probiotics for the prevention of NEC. Bifidobacteria are gram-positive anaerobic bacteria that predominantly colonize the gut in healthy breast-feeding neonates but are much less prevalent in the intestinal tract of premature infants at highest risk for NEC. Preliminary investigations in a neonatal rat model of NEC using probiotic supplementation have demonstrated a significant reduction in the incidence of NEC. 43, 46 Future human clinical trials are needed.

Nonabsorbable broad-spectrum antibiotics that inhibit bacterial growth have been administered in an effort to prevent NEC. The use of an enteral aminoglycoside (e.g., kanamycin or gentamicin) has been proposed as a means to decrease the incidence of perforation during nonoperative treatment. However, randomized, controlled studies found no difference in the clinical course, complications, or mortality rate between infants who received the antibiotic and those who did not. 74, 194 In addition, oral aminoglycosides may be absorbed across the damaged gut, which can lead to increased serum levels and thereby potentially contribute to drug toxicity. Resistant strains of bacteria emerged after treatment with enteral kanamycin, 74 and there is the omnipresent risk for promotion of the growth of fungal species. In a recent randomized placebo-controlled study of oral vancomycin in preventing NEC in preterm infants, Siu et al. 271 reported a 50% reduction in the incidence of NEC in the vancomycin group in comparison to controls.

The available studies do not support the routine administration of enteral antibiotics to all high-risk premature infants, many of whom have poor intestinal motility. Effectiveness has not been proved, and resistant organisms may develop. Administering specific antibiotics to infants may be indicated in nurseries in which an outbreak of NEC is associated with a specific organism.

Carrion and Egan 49 conducted a small prospective doubleblinded study in which feedings given to premature infants were acidified with HCl to a pH of 2.5 to 5.5. Acidification of feedings significantly decreased the rate of gastric bacterial colonization in infants with a gastric pH less than 4.0. They also found a significantly lower incidence of NEC in infants given acidified feedings than in controls.

The effects of PAF are mediated by receptors, and many compounds that function as receptor antagonists or enzymes that degrade these proteins have been described. Animal experiments using PAF antagonists (WEB 2086, WEB 2170, SRI 63-441) or PAF-degrading enzyme (PAF acetylhydrolase) have demonstrated the capacity to prevent bowel injury produced by the administration of endotoxin or hypoxia in rats. 47, 115 PAF acetylhydrolase is also known to be present in breast milk. Despite promising results in animal models, no human trials using PAF antagonists or degrading enzyme in the treatment of NEC have been reported.

Resection and primary anastomosis in necrotizing enterocolitis

A case of perforation of the ileum in a newborn infant with operation and recovery

Protective effect of dietary supplementation with L-arginine and L-carnitine on hypoxia/ reoxygenation-induced necrotizing enterocolitis in young mice

Interleukin-11 enhances small intestine absorptive function and mucosal mass after intestinal adaptation

Nitric oxide synthases: Structure, function and inhibition

A critical role for nitric oxide in intestinal barrier function and dysfunction

Localized intestinal perforation after enteral administration of indomethacin in premature infants

Arginine supplementation prevents necrotizing enterocolitis in premature infants

The relationship of neonatal alimentation practices to the occurrence of endemic necrotizing enterocolitis

Interleukin-4 acts as an inducer of decay-accelerating factor gene expression in human intestinal epithelial cells

Structure of the human cyclooxygenase-2 gene

Intestinal glycosidase activities in the human embryo, fetus, and newborn

Peri-cholecystic hyper-echogenicity in necrotizing enterocolitis: A specific sonographic sign?

Laparotomy or drain for perforated necrotizing enterocolitis: Who gets what and why

Pathology of neonatal necrotizing enterocolitis: A ten-year experience

Maternal-fetal and neonatal effects of in utero cocaine exposure

An experimental study of neonatal enterocolitis-the importance of breast milk

Nitric oxide modulates water and electrolyte transport in the ileum

Development of the enteric nervous system

Necrotizing Enterocolitis

A decreased incidence of necrotizing enterocolitis after prenatal glucocorticoid therapy

Neonatal necrotizing enterocolitis: Therapeutic decisions based upon clinical staging

Necrotizing enterocolitis in the premature infant

Gestational evolution of small intestine motility in preterm and term infants

Prolonging small feeding volumes early in life decreases the incidence of necrotizing enterocolitis in very low birth weight infants

Enteric colonization in sporadic neonatal necrotizing enterocolitis

Nosocomial necrotising enterocolitis outbreaks: Epidemiology and control measures

Necrotizing enterocolitis in full-term neonates

Immunologic dissonance: A continuing evolution in our understanding of the systemic inflammatory response syndrome and the multiple organ dysfunction syndrome

Necrotizing enterocolitis in low birth weight infants fed elemental formula

Carbohydrate malabsorption in necrotizing enterocolitis

Clustering of necrotizing enterocolitis: Interruption by infection-control methods

Development and function of the intestinal mucosal barrier

Preventing necrotizing enterocolitis in neonates

Host defense mechanisms of human milk and their relations to enteric infections and necrotizing enterocolitis

Neonatal imaging: The radiology of necrotizing enterocolitis

The changing face of surgical indications for necrotizing enterocolitis

Maternal cocaine abuse resulting in necrotizing enterocolitis-an experimental study in a rat model

The role of human milk in necrotizing enterocolitis

Role of asphyxia and feeding in a neonatal rat model of necrotizing enterocolitis

The platelet-activating factor receptor antagonist WEB 2170 prevents necrotizing enterocolitis in rats

The role of endogenous nitric oxide and platelet-activating factor in hypoxiainduced intestinal injury in rats

Serum PAF acetylhydrolase increases during neonatal maturation

Neonatal necrotizing enterocolitis: Possible role of probiotic supplementation

New concepts in necrotizing enterocolitis

The role of recombinant platelet-activating factor acetylhydrolase in a neonatal rat model of necrotizing enterocolitis

Bifidobacterial supplementation reduces the incidence of necrotizing enterocolitis in a neonatal rat model

Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis

Hypoxia causes ischemic bowel necrosis in rats: The role of platelet-activating factor

Prevention of neonatal necrotizing enterocolitis

Ontogeny of EGF receptors in the human gut

Survival, morbidity, and resource use in infants of 25 weeks' gestational age or less

Necrotizing enterocolitis in infants with very low birth weight

Expression of inducible nitric oxide synthase mRNA in rat digestive tissues after endotoxin and its role in intestinal mucosal injury

Breath hydrogen excretion as a screening for the early diagnosis of necrotizing enterocolitis

Molecular mechanisms contributing to necrotizing enterocolitis

Modulation of human intestinal epithelial cell IL-8 secretion by human milk factors

The epidermal growth factor (EGF)

Bcl-2 inhibits ischemia-reperfusion-induced apoptosis in the intestinal epithelium of transgenic mice

The effect of aminophylline on gastrointestinal blood flow and oxygen metabolism in the conscious newborn lamb

Reactions between nitric oxide, superoxide, and peroxynitrite: Footprints of peroxynitrite in vivo

Maternal cocaine abuse and necrotizing enterocolitis: Outcome and survival

The radiology of neonatal necrotizing enterocolitis: A review of 47 cases and the literature

Role of theophylline in pathogenesis of necrotizing enterocolitis

Role of bacterial translocation in necrotizing enterocolitis

Experimental production of necrotizing enterocolitis in newborn goats

Peritoneal drainage as primary management in necrotizing enterocolitis: A prospective study

Immunoglobulin A supplementation abrogates bacterial translocation and preserves the architecture of the intestinal epithelium

Recombinant human interleukin-11 prevents mucosal atrophy and bowel shortening in the defunctionalized intestine

Use of L-arginine in the treatment of experimental necrotizing enterocolitis

Characteristics of perinatal cocaine exposed infants with necrotizing enterocolitis

Beneficial effects of early hypocaloric enteral feeding on neonatal gastrointestinal function: Preliminary report of a randomized trial

Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model

Circulating pro-and counterinflammatory cytokine levels and severity in necrotizing enterocolitis

Additional experience with routine use of oral kanamycin prophylaxis for necrotizing enterocolitis in infants under 1,500 grams

Outcome of perforated necrotizing enterocolitis in the very low birth weight neonate may be independent of the type of surgical treatment

Prevention of necrotizing enterocolitis in low-birth-weight infants by IgA-IgG feeding

Peritoneal drainage under local anesthesia for necrotizing enterocolitis

Origin of mural gas in necrotizing enterocolitis

The role of plateletactivating factor in a neonatal piglet model of necrotising enterocolitis

Immunoreactive epidermal growth factor receptors are present in gastrointestinal epithelial cells of preterm infants with necrotising enterocolitis

Necrotizing enterocolitis: Extent of disease and surgical treatment

Vitamin E and necrotizing enterocolitis

Treatment of septic shock with the tumour necrosis factor: Fc fusion protein

The role of inflammatory cytokine and nitric oxide in the pathogenesis of necrotizing enterocolitis

Analysis of bowel perforation in necrotizing enterocolitis

Urinary D-lactate excretion in infants with necrotizing enterocolitis

Use of neonatal intensive care unit as a safe place for neonatal surgery

Bauchfellentzündung beim Neugeborenen in folge von Perforation des Ileums

Effects of indomethacin in premature infants with patent ductus arteriosus: Results of a national collaborative study

Argininesupplemented diets improve survival in gut-derived sepsis and peritonitis by modulating bacterial clearance. The role of nitric oxide

Pathogenesis of neonatal Escherichia coli meningitis: Induction of bacteremia and meningitis in infant rats fed E coli K1

Antiinflammatory properties of human milk

Peritoneal drainage as definitive management of intestinal perforation in extremely low-birth-weight infants

Experimental model of ischemic bowel necrosis: The role of platelet-activating factor and endotoxin

Nitroglycerin attenuates the bowel damage of necrotizing enterocolitis in a rabbit model

Necrotizing enterocolitis after Renografin-76 treatments of meconium ileus

Increased risk of necrotizing enterocolitis in premature infants with patent ductus arteriosus treated with indomethacin

Changing trends in necrotizing enterocolitis: Experience with 302 cases in two decades

Comparative effects of indomethacin, prostaglandin E, and ibuprofen on bowel ischemia

Necrotizing enterocolitis among neonates in the United States

Prenatal and postnatal corticosteroid therapy to prevent neonatal necrotizing enterocolitis: A controlled trial

Frequency of and risk factors for necrotizing enterocolitis in infants born before 33 weeks of gestation

Ileal cytokine dysregulation in experimental necrotizing enterocolitis is reduced by epidermal growth factor

Bioactive factors in human milk

Platelet activating factor: A biologically active phosphoglyceride

The effects of intrauterine cocaine exposure on the respiratory status of the very low birth weight infant

Cytokine elevations in critically ill infants with sepsis and necrotizing enterocolitis

The osmotic effect of water soluble contrast media on circulating plasma volume

Healthy People 2000: National Health Promotion and Disease Prevention Objective

Systemic and mesenteric vascular effects of platelet-activating factor and cocaine

Epidermal growth factor in saliva and serum of infants with necrotising enterocolitis

Continuous positive airway pressure versus theophylline for apnea in preterm infants

NICHD Neonatal Research Network: Decreasing mortality associated with the introduction of surfactant therapy: An observational study of neonates weighing 601 to 1300 grams at birth

Complications after surgical intervention for necrotizing enterocolitis: A multicenter review

Neonatal necrotizing enterocolitis: Clinical considerations and pathogenetic concepts

Platelet activating factor is an endogenous mediator for bowel necrosis in endotoxemia

Role of nitric oxide in maintaining vascular integrity in endotoxininduced acute intestinal damage in the rat

Hematologic abnormalities in severe neonatal necrotizing enterocolitis

P53-dependent radiation-induced crypt intestinal epithelial cell apoptosis is mediated in part through TNF-TNFR1 system

Serum acute phase reactants in necrotizing enterocolitis

Biologic activities and mechanisms of action of tumor necrosis factor-alpha/cachectin

Intestinal strictures after necrotizing enterocolitis

Intestinal epithelial apoptosis initiates gross bowel necrosis in an experimental rat model of neonatal necrotizing enterocolitis

Relationship of prolonged pharmacologic serum levels of vitamin E to incidence of sepsis and necrotizing enterocolitis in infants with birth weight 1500 grams or less

Developmental pathogenesis of defects associated with prenatal cocaine exposure: Fetal vascular disruption

Gastrointestinal mucosal regeneration: Role of growth factors

Erythropoietin in the neonate

Why is erythropoietin present in human milk? Studies of erythropoietin receptors on enterocytes of human and rat neonates

Erythropoietin acts as a trophic factor in neonatal rat intestine

Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus

Neonatal necrotizing enterocolitis: An overview

The incidence of necrotizing enterocolitis after introducing standardized feeding schedules for infants between 1250 and 2500 grams and less than 35 weeks of gestation

Recognition and medical management of necrotizing enterocolitis

Contrast enema diagnosis of necrotizing enterocolitis

Risk factors associated with fungal peritonitis in very low birth weight neonates with severe necrotizing enterocolitis: A case-control study

Rapid versus slow rate of advancement of feedings for promoting growth and preventing necrotizing enterocolitis in parenterally fed low-birth-weight infants

Early versus delayed initiation of progressive enteral feedings for parenterally fed low birth weight or preterm infants

Maternal cocaine abuse resulting in necrotizing enterocolitis. An experimental study in a rat model. II. Results of perfusion studies

Influence of two infant formulas and human milk on the development of faecal flora in newborn infants

Neonatal necrotizing enterocolitis: Implications for an infectious disease

Neonatal necrotizing enterocolitis: Bridging the basic science with the clinical disease

Neonatal necrotizing enterocolitis: A nine-year experience

Neonatal necrotizing enterocolitis in the absence of pneumatosis

Neonatal necrotizing enterocolitis

Epidemiologic study of necrotizing enterocolitis among low-birth-weight infants

Necrotizing enterocolitis in neonates fed human milk

Necrotizing enterocolitis: Research agenda for a disease of unknown etiology and pathogenesis

Neonatal necrotizing enterocolitis: Pathogenesis, classification, and spectrum of illness

Human milk as a potential enteral source of erythropoietin

Ultrasonographic diagnosis of gangrenous bowel in neonatal necrotizing enterocolitis

Kosloske AM: Surgery for necrotizing enterocolitis

Kosloske AM: Epidemiology of necrotizing enterocolitis

Kosloske AM: Indications for operation in necrotizing enterocolitis revisited

Necrotizing enterocolitis of the neonate

Indications for operation in acute necrotizing enterocolitis of the neonate

Indomethacin administration after temporary ischemia causes bowel necrosis in mice

The relationship of feeding to necrotizing enterocolitis

Ischemia-reperfusion in feline small intestine: A role for nitric oxide

Inducible nitric oxide synthase: A little bit of good in all of us

Platelet-activating factor-induced mucosal dysfunction: Role of oxidants and granulocytes

Nitric oxide and intestinal inflammation

Intestinal perforation associated with indomethacin treatment in premature infants

Erythropoietin protects against necrotizing enterocolitis of newborn rats by the inhibiting nitric oxide formation

Portal venous air-an old sign and new operative indication for necrotizing enterocolitis

Feeding practices for infants weighing less than 1500 g at birth and the pathogenesis of necrotizing enterocolitis

Failure of delayed oral feedings to prevent necrotizing enterocolitis. Results of study in very-low-birth-weight neonates

Mucosal permeability in the immature rat intestine: Effects of ischemiareperfusion, cold stress, hypoxia, and drugs

Proinflammatory effects of IL-10 during human endotoxemia

Pathogenesis of neonatal necrotizing enterocolitis

Enteral human IgG for prevention of necrotising enterocolitis: A placebo-controlled, randomized trial

Erythropoietin and the incidence of necrotizing enterocolitis in infants with very low birth weights

Necrotizing enterocolitis and hematopoietic cytokines

Neonatal necrotizing enterocolitis: A retrospective and multicentric review of 331 cases

Very low birth weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network

Critical evaluation of the persistent loop sign in necrotizing enterocolitis

Peritoneal drainage as definitive treatment for intestinal perforation in infants with extremely low birth weight (less than 750 grams)

Trophic effects of interleukin-11 in rats with experimental short bowel syndrome

Time of onset of necrotizing enterocolitis in newborn infants with known prenatal cocaine exposure

Breast milk and neonatal necrotizing enterocolitis

Magnetic resonance imaging of intestinal necrosis in preterm infants

Endogenous nitric oxide protects against platelet-activating factor-induced bowel injury in the rat

Increase in plasma platelet-activating factor levels in enterally fed preterm infants

Indomethacin therapy on the first day of life in infants with very low birth weight

Influence of epidermal growth factor on the development of sucking mouse intestinal mucosa

Necrotizing enterocolitis in the unfed infant

Early operation with intestinal diversion for necrotizing enterocolitis

Necrotizing enterocolitis in full-term or near-term infants: Risk factors

Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and nonseptic origin

NF-κB as a primary regulator of the stress response

Sonographic detection of portal venous gas in infants with necrotizing enterocolitis

Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor

Probiotics for preterm infants?

Nitric oxide release in response to gut injury

Gentamicin absorption during prophylactic use for necrotizing enterocolitis

Necrotizing enterocolitis in premature infants

Portal venous air: The poor prognosis persists

Does patient age or intestinal pathology influence the bacteria found in cases of necrotizing enterocolitis

Nitric oxide: Physiology, pathophysiology, and pharmacology

Necrotizing enterocolitis-endemic vs epidemic form

Management of necrotizing enterocolitis by "patch, drain, and wait

Successful use of the "patch, drain, and wait" laparotomy approach to perforated necrotizing enterocolitis: Is hypoxia-triggered "good angiogenesis" involved?

Hemodynamic effects of intravenous cocaine on the pregnant ewe and fetus

Peritoneal drainage as primary management of perforated NEC in the very low birth weight infant

The radiology of necrotizing enterocolitis

A meta-analysis of peritoneal drainage versus laparotomy for perforated necrotizing enterocolitis

Platelet-activating factor acetylhydrolase in term and preterm human milk: A preliminary report

Enterostomy in necrotizing enterocolitis: An analysis of techniques and timing of closure

Expression of inducible nitric oxide synthase and interleukin-12 in experimental necrotizing enterocolitis

Intestinal cytokine gene expression in infants with acute necrotizing enterocolitis: Interleukin-11 mRNA expression inversely correlates with extent of disease

Inflammation in the developing human intestine: A possible pathophysiologic contribution to necrotizing enterocolitis

Nitric oxide synthases: Roles, tolls, and controls

Arachidonic acid metabolism

Update on host defense and immunonutrients

Cytokine profiles of cultured microvascular endothelial cells from the human intestine

Neonatal complications after administration of indomethacin for preterm labor

Nowicki P: Intestinal ischemia and necrotizing enterocolitis

High morbidity of enterostomy and its closure in premature infants with necrotizing enterocolitis

Erythropoietin to prevent and treat the anemia of prematurity

Neonatal necrotizing enterocolitis

Early enteral feeding does not affect the incidence of necrotizing enterocolitis

Necrotizing enterocolitis in full-term infants

Protective effects of recombinant human interleukin-10 on intestines of hypoxia-induced necrotizing enterocolitis in immature rats

Die spontane dickdarm Rupture der Neugeborenen

ICAM-1, and VCAM-1 gene expression and cytokine production in human duodenal fibroblasts stimulated with lipopolysaccharide, IL-1 alpha and TNF-alpha

Development of the gastrointestinal mucosal barrier. III. Evidence for structural differences in microvillus membranes from newborn and adult rabbits

IL-6 production in human intestinal epithelial cells following stimulation with IL-1 beta is associated with activation of the transcription factor NF-kappa B

Role of oxygenderived free radicals in digestive tract diseases

Nitric oxide donors reduce the rise in reperfusion-induced intestinal mucosal permeability

Necrotizing enterocolitis: Pathogenesis and treatment

Surgical treatment of infants with necrotizing enterocolitis

Laparoscopy assists surgical decision making in infants with necrotizing enterocolitis

Serum cytokine levels in human septic shock: Relation to multiple-system organ failure and mortality

Why is epidermal growth factor present in the gut lumen?

Necrotizing enterocolitis: Incidence, operative care, and outcome

Cocaine: A risk factor for necrotizing enterocolitis

Role of nitric oxide and peroxynitrite in gut barrier failure

Peroxynitrite inhibits enterocytes' proliferation and modulates Src kinase activity in vitro

Continuous nasogastric milk feeding versus intermittent bolus milk feeding for premature infants less than 1500 grams

Roles of nitric oxide synthases in platelet-activating factor-induced intestinal necrosis in rats

Colonic changes following necrotizing enterocolitis in the newborn

Plateletactivating factor in infants at risk for necrotizing enterocolitis

Peroxynitrite-induced membrane lipid peroxidation: The cytotoxic potential of superoxide and nitric oxide

Randomized trial of "slow" versus "fast" feed advancements on the incidence of necrotizing enterocolitis in very low birth weight infants

Growth factor concentrations and growth-promoting activity in human milk following premature birth

Surgical treatment of necrotizing enterocolitis and the short bowel syndrome

Neonatal necrotizing enterocolitis: Experience with 100 consecutive surgical patients

Milk antigen absorption in the preterm and term neonate

Xanthines and necrotizing enterocolitis

L'entcolite ulceronecrotique du premature

Necrotizing enterocolitis

The early diagnosis of gram negative septicemia in the pediatric surgical patient

The neonatal response to Gastrografin enema

The mechanisms of thrombocytopenia in experimental gram-negative septicemia

Necrotizing enterocolitis in the extremely low birthweight infant

Gastrografininduced hypertonicity

Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives

Acute necrotizing enterocolitis in infancy: A review of 64 cases

Feeding strategies for premature infants: Randomized trial of gastrointestinal priming and tube-feeding method

Role of bacterial toxins in neonatal necrotizing enterocolitis

Delta toxin activity in coagulasenegative staphylococci from the bowels of neonates

Deltalike toxin produced by coagulase-negative staphylococci is associated with necrotizing enterocolitis

Comparison of two antibiotic regimens for neonatal necrotizing enterocolitis

Endotoxinemia in neonates with necrotizing enterocolitis

Uer eine besondere schwere Verlaufende form von Enteritis beim Saugling

Morbidity of low-birthweight infants with intrauterine cocaine exposure

Interleukin-1 beta activates expression of cyclooxygenase-2 and inducible nitric oxide synthase in primary hippocampal neuronal culture: Platelet-activating factor as a preferential mediator of cyclooxygenase-2 expression

Diminished epidermal growth factor levels in infants with necrotizing enterocolitis

Intestinal microbial translocation: Immunologic consequences and effects of interleukin-4

Follow-up for infants with necrotizing enterocolitis

Cyclooxygenase 2 is induced in colonic epithelial cells in inflammatory bowel disease

Double blind, randomized, placebo controlled study of oral vancomycin in prevention of necrotizing enterocolitis in preterm, very low birth weight infants

The hidden mortality in surgically-treated necrotizing enterocolitis: Fungal sepsis

Survival after necrotizing enterocolitis in infants weighing less than 1,000 grams: 25 years' experience at a single institution

Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators

Evaluation and treatment of thrombocytopenia in the neonatal intensive care unit

Anastomotic ulceration: A late complication of ileocolonic anastomosis

Growth and neurodevelopmental outcome of very low birthweight infants with necrotizing enterocolitis

The ontogeny of human mucosal barrier immunity

Role of nitric oxide in gastrointestinal and hepatic function and diseases

Late morbidity among survivors of necrotizing enterocolitis

Epidemiology of necrotizing enterocolitis

Recurrent necrotizing enterocolitis

Is there a role for high jejunostomy in the management of severe necrotising enterocolitis?

Bowel necrosis induced by tumor necrosis factor in rats is mediated by platelet-activating factor

Change in the ratio of interleukin-6 to interleukin-10 predicts a poor outcome in patients with systemic inflammatory response syndrome

Necrotizing enterocolitis as a complication

Nitric oxide synthase induction and intestinal cell viability in rats

Neonatal necrotizing enterocolitis: The relationship of age at the time of onset and prognosis

Thelander HE: Perforation of the gastro-intestinal tract of the newborn infant

Neonatal necrotizing enterocolitis: An update on etiology, diagnosis and treatment

Necrotizing enterocolitis in very low birth weight infants: Biodemographic and clinical correlates

Gastrointestinal host defense and necrotizing enterocolitis

Necrotizing enterocolitis in very low birth weight infants: Biodemographic and clinical correlates. National Institute of Child Health and Human Development Neonatal Research Network

Development of gastrointestinal mucosal barrier. I. The effect of age of intestinal permeability to macromolecules

Outbreak of necrotizing enterocolitis associated with Enterobacter sakazakii in powdered milk formula

Liver hemorrhage during laparotomy in patients with necrotizing enterocolitis

Anti-inflammatory cytokine profile and mortality in febrile patients

Avoidance of stomas and delayed anastomosis for bowel necrosis: The 'clip and drop-back' technique

The clinical significance of thrombocytopenia in neonates with necrotizing enterocolitis

Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions

Neurodevelopmental and functional outcomes of extremely low-birth-weight infants in the National Institute of Child Health and Human Development Neonatal Research Network

Enterostomy and its closure in newborns

Proposed mechanism for the translocation of intestinal bacteria

Quantitative study of the aerobic and anaerobic fecal flora in neonatal enterocolitis

The persistent loop sign in neonatal necrotizing enterocolitis: A new indication for surgical intervention?

Hypertonic formula resulting from added oral medications

Xanthines and necrotizing enterocolitis

Prostaglandin endoperoxide synthase: Why two isoforms?

Unsuspected hyperosmolarity of oral solutions contributing to necrotizing enterocolitis in very low birth weight infants

Age at onset of necrotizing enterocolitis: An epidemiologic analysis

Necrotizing enterocolitis in full-term infants. A case-control study

Effect of cocaine on uterine blood flow and fetal oxygenation

Rapid advances in feeding increase the risk of necrotizing enterocolitis in very low birth weight infants

Effect of heat shock and endotoxin stress on enterocytes viability apoptosis and function varies based on whether the cells are exposed to heat shock or endotoxin first

Development and differences of intestinal flora in the neonatal period in breastfed and bottle-fed infants

Entamoeba histolytica stimulates interleukin-8 from human colonic epithelial cells without parasiteenterocyte contact

Plasma L-arginine concentrations in premature infants with necrotizing enterocolitis